<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1168" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1168/" /><meta name="ncbi_pagename" content="Congenital Myasthenic Syndromes - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Congenital Myasthenic Syndromes - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Congenital Myasthenic Syndromes" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/07/14" /><meta name="citation_author" content="Angela Abicht" /><meta name="citation_author" content="Juliane Müller, S" /><meta name="citation_author" content="Hanns Lochmüller" /><meta name="citation_pmid" content="20301347" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1168/" /><meta name="citation_keywords" content="Congenital Myasthenia" /><meta name="citation_keywords" content="Congenital Myasthenia" /><meta name="citation_keywords" content="43 kDa receptor-associated protein of the synapse" /><meta name="citation_keywords" content="Acetylcholine receptor subunit alpha" /><meta name="citation_keywords" content="Acetylcholine receptor subunit beta" /><meta name="citation_keywords" content="Acetylcholine receptor subunit delta" /><meta name="citation_keywords" content="Acetylcholine receptor subunit epsilon" /><meta name="citation_keywords" content="Acetylcholinesterase collagenic tail peptide" /><meta name="citation_keywords" content="Agrin" /><meta name="citation_keywords" content="Alpha-1,3/1,6-mannosyltransferase ALG2" /><meta name="citation_keywords" content="Choline O-acetyltransferase" /><meta name="citation_keywords" content="Collagen alpha-1(XIII) chain" /><meta name="citation_keywords" content="Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1" /><meta name="citation_keywords" content="High affinity choline transporter 1" /><meta name="citation_keywords" content="Laminin subunit beta-2" /><meta name="citation_keywords" content="Low-density lipoprotein receptor-related protein 4" /><meta name="citation_keywords" content="Mannose-1-phosphate guanyltransferase beta" /><meta name="citation_keywords" content="Muscle, skeletal receptor tyrosine-protein kinase" /><meta name="citation_keywords" content="Plectin" /><meta name="citation_keywords" content="Prolyl endopeptidase-like" /><meta name="citation_keywords" content="Protein Dok-7" /><meta name="citation_keywords" content="Sodium channel protein type 4 subunit alpha" /><meta name="citation_keywords" content="Synaptosomal-associated protein 25" /><meta name="citation_keywords" content="Synaptotagmin-2" /><meta name="citation_keywords" content="Tricarboxylate transport protein, mitochondrial" /><meta name="citation_keywords" content="UDP-N-acetylglucosamine transferase subunit ALG14 homolog" /><meta name="citation_keywords" content="UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase" /><meta name="citation_keywords" content="Unconventional myosin-IXa" /><meta name="citation_keywords" content="AGRN" /><meta name="citation_keywords" content="ALG14" /><meta name="citation_keywords" content="ALG2" /><meta name="citation_keywords" content="CHAT" /><meta name="citation_keywords" content="CHRNA1" /><meta name="citation_keywords" content="CHRNB1" /><meta name="citation_keywords" content="CHRND" /><meta name="citation_keywords" content="CHRNE" /><meta name="citation_keywords" content="COL13A1" /><meta name="citation_keywords" content="COLQ" /><meta name="citation_keywords" content="DOK7" /><meta name="citation_keywords" content="DPAGT1" /><meta name="citation_keywords" content="GFPT1" /><meta name="citation_keywords" content="GMPPB" /><meta name="citation_keywords" content="LAMB2" /><meta name="citation_keywords" content="LRP4" /><meta name="citation_keywords" content="MUSK" /><meta name="citation_keywords" content="MYO9A" /><meta name="citation_keywords" content="PLEC" /><meta name="citation_keywords" content="PREPL" /><meta name="citation_keywords" content="RAPSN" /><meta name="citation_keywords" content="SCN4A" /><meta name="citation_keywords" content="SLC25A1" /><meta name="citation_keywords" content="SLC5A7" /><meta name="citation_keywords" content="SNAP25" /><meta name="citation_keywords" content="SYT2" /><meta name="citation_keywords" content="Congenital Myasthenic Syndromes" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Congenital Myasthenic Syndromes" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Angela Abicht" /><meta name="DC.Contributor" content="Juliane Müller, S" /><meta name="DC.Contributor" content="Hanns Lochmüller" /><meta name="DC.Date" content="2016/07/14" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1168/" /><meta name="description" content="Congenital myasthenic syndromes (designated as CMS throughout this entry) are characterized by fatigable weakness of skeletal muscle (e.g., ocular, bulbar, limb muscles) with onset at or shortly after birth or in early childhood; rarely, symptoms may not manifest until later in childhood. Cardiac and smooth muscle are usually not involved. Severity and course of disease are highly variable, ranging from minor symptoms to progressive disabling weakness. In some subtypes of CMS, myasthenic symptoms may be mild, but sudden severe exacerbations of weakness or even sudden episodes of respiratory insufficiency may be precipitated by fever, infections, or excitement. Major findings of the neonatal-onset subtype include: respiratory insufficiency with sudden apnea and cyanosis; feeding difficulties; poor suck and cry; choking spells; eyelid ptosis; and facial, bulbar, and generalized weakness. Arthrogryposis multiplex congenita may also be present. Stridor in infancy may be an important clue to CMS. Later childhood-onset subtypes show abnormal muscle fatigability with difficulty in activities such as running or climbing stairs; motor milestones may be delayed; fluctuating eyelid ptosis and fixed or fluctuating extraocular muscle weakness are common presentations." /><meta name="og:title" content="Congenital Myasthenic Syndromes" /><meta name="og:type" content="book" /><meta name="og:description" content="Congenital myasthenic syndromes (designated as CMS throughout this entry) are characterized by fatigable weakness of skeletal muscle (e.g., ocular, bulbar, limb muscles) with onset at or shortly after birth or in early childhood; rarely, symptoms may not manifest until later in childhood. Cardiac and smooth muscle are usually not involved. Severity and course of disease are highly variable, ranging from minor symptoms to progressive disabling weakness. In some subtypes of CMS, myasthenic symptoms may be mild, but sudden severe exacerbations of weakness or even sudden episodes of respiratory insufficiency may be precipitated by fever, infections, or excitement. Major findings of the neonatal-onset subtype include: respiratory insufficiency with sudden apnea and cyanosis; feeding difficulties; poor suck and cry; choking spells; eyelid ptosis; and facial, bulbar, and generalized weakness. Arthrogryposis multiplex congenita may also be present. Stridor in infancy may be an important clue to CMS. Later childhood-onset subtypes show abnormal muscle fatigability with difficulty in activities such as running or climbing stairs; motor milestones may be delayed; fluctuating eyelid ptosis and fixed or fluctuating extraocular muscle weakness are common presentations." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1168/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cms/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1168/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A5D65E040AD110000000000A30039.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1168_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1168_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cmd-overview/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/csc-dys/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1168_"><span class="title" itemprop="name">Congenital Myasthenic Syndromes</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Congenital Myasthenia</div><p class="contrib-group"><span itemprop="author">Angela Abicht</span>, MD, <span itemprop="author">Juliane M&#x000fc;ller, S</span>, PhD, and <span itemprop="author">Hanns Lochm&#x000fc;ller</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1168_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1168_ai__"><div class="contrib half_rhythm"><span itemprop="author">Angela Abicht</span>, MD<div class="affiliation small">Department of Neurology<br />Friedrich-Baur Institute;<br />Medical Genetics Center (MGZ)<br />Munich, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.nehcneum-zgm@thciba.alegna" class="oemail">ed.nehcneum-zgm@thciba.alegna</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Juliane M&#x000fc;ller, S</span>, PhD<div class="affiliation small">John Walton Muscular Dystrophy Research Centre<br />Institute of Genetic Medicine<br />Newcastle University<br />Newcastle upon Tyne, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.eltsacwen@relleum.enailuj" class="oemail">ku.ca.eltsacwen@relleum.enailuj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Hanns Lochm&#x000fc;ller</span>, MD<div class="affiliation small">John Walton Muscular Dystrophy Research Centre<br />Institute of Genetic Medicine<br />Newcastle University<br />Newcastle upon Tyne, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcn@rellumhcol.snnah" class="oemail">ku.ca.lcn@rellumhcol.snnah</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 9, 2003</span>; Last Update: <span itemprop="dateModified">July 14, 2016</span>.</p><p><em>Estimated reading time: 40 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cms.Summary" itemprop="description"><h2 id="_cms_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Congenital myasthenic syndromes (designated as CMS throughout this entry) are characterized by fatigable weakness of skeletal muscle (e.g., ocular, bulbar, limb muscles) with onset at or shortly after birth or in early childhood; rarely, symptoms may not manifest until later in childhood. Cardiac and smooth muscle are usually not involved. Severity and course of disease are highly variable, ranging from minor symptoms to progressive disabling weakness. In some subtypes of CMS, myasthenic symptoms may be mild, but sudden severe exacerbations of weakness or even sudden episodes of respiratory insufficiency may be precipitated by fever, infections, or excitement. Major findings of the neonatal-onset subtype include: respiratory insufficiency with sudden apnea and cyanosis; feeding difficulties; poor suck and cry; choking spells; eyelid ptosis; and facial, bulbar, and generalized weakness. Arthrogryposis multiplex congenita may also be present. Stridor in infancy may be an important clue to CMS. Later childhood-onset subtypes show abnormal muscle fatigability with difficulty in activities such as running or climbing stairs; motor milestones may be delayed; fluctuating eyelid ptosis and fixed or fluctuating extraocular muscle weakness are common presentations.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of CMS is based on clinical findings, a decremental EMG response of the compound muscle action potential (CMAP) on low-frequency (2-3 Hz) stimulation, a positive response to acetylcholinesterase (AchE) inhibitors, absence of anti-acetylcholine receptor (AChR) and anti-MuSK antibodies in the serum, and lack of improvement of clinical symptoms with immunosuppressive therapy. Pathogenic variants in one of multiple genes encoding proteins expressed at the neuromuscular junction are currently known to be associated with subtypes of CMS. The most commonly associated genes include: <i>CHAT</i>, <i>CHRNE</i>, <i>COLQ</i>, <i>DOK7</i>, <i>GFPT1</i>, and <i>RAPSN</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Most individuals with CMS benefit from AChE inhibitors and/or the potassium channel blocker 3,4-diaminopyridine (3,4-DAP); however, caution must be used in giving 3,4-DAP to young children and individuals with fast-channel CMS (FCCMS). Individuals with <i>COLQ</i> and <i>DOK7</i> pathogenic variants usually do not respond to long-term treatment with AChE inhibitors. Some individuals with slow-channel CMS (SCCMS) are treated with quinidine, which has some major side effects and may be detrimental in individuals with AChR deficiency. Fluoxetine is reported to be beneficial for SCCMS. Ephedrine and albuterol have been beneficial in several individuals, especially as a therapeutic option for those with <i>DOK7</i> or <i>COLQ</i> pathogenic variants.</p><p><i>Prevention of primary manifestations:</i> Prophylactic anticholinesterase therapy to prevent sudden respiratory insufficiency or apneic attacks provoked by fever or infections in those with pathogenic variants in <i>CHAT</i> or <i>RAPSN</i>. Parents of infants are advised to use apnea monitors and be trained in CPR.</p><p><i>Agents/circumstances to avoid:</i> Drugs known to affect neuromuscular transmission and exacerbate symptoms of myasthenia gravis (e.g., ciprofloxacin, chloroquine, procaine, lithium, phenytoin, beta-blockers, procainamide, quinidine).</p><p><i>Evaluation of relatives at risk:</i> If the pathogenic variants in the family are known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk asymptomatic family members, especially newborns or young children, who could benefit from early treatment to prevent sudden respiratory failure.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Congenital myasthenic syndromes are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> or an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p>In <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> CMS (AR-CMS), the parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes and therefore carry one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Heterozygotes (carriers) are asymptomatic. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</p><p>In <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> CMS (AD-CMS), some individuals have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent while others have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by <i>de novo</i> pathogenic variants is unknown. Each child of an individual with AD-CMS has a 50% chance of inheriting the pathogenic variant.</p><p>Prenatal testing and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</p></div></div><div id="cms.Diagnosis"><h2 id="_cms_Diagnosis_">Diagnosis</h2><div id="cms.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Congenital myasthenic syndromes (CMS) <b>should be suspected</b> in individuals with the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">A history of fatigable weakness involving ocular, bulbar, and limb muscles with onset at or shortly after birth or in early childhood. Post-childhood onset has been observed, but is rare [<a class="bk_pop" href="#cms.REF.burke.2003.826">Burke et al 2003</a>, <a class="bk_pop" href="#cms.REF.beeson.2005.498">Beeson et al 2005</a>, <a class="bk_pop" href="#cms.REF.m_ller.2007a.1497">M&#x000fc;ller et al 2007a</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">A decremental EMG response of the compound muscle action potential (CMAP) on low-frequency (2-3 Hz) stimulation (see <a href="#cms.Testing">Testing</a>, <b>Electrophysiologic testing</b>)</div></li><li class="half_rhythm"><div class="half_rhythm">A positive response to acetylcholinesterase (AchE) inhibitors (see <a href="#cms.Testing">Testing</a>, <b>Response to acetylcholinesterase inhibitors</b>)</div></li><li class="half_rhythm"><div class="half_rhythm">Absence of anti-acetylcholine receptor (anti-AChR) and anti-MuSK antibodies in the serum</div><div class="half_rhythm">Note: (1) Absence of anti-AChR antibodies in the serum can help distinguish CMS from myasthenia gravis (MG), but does not exclude seronegative types of MG or MG with anti-MuSK antibodies [<a class="bk_pop" href="#cms.REF.hoch.2001.365">Hoch et al 2001</a>]. (2) One case of autoimmune MG developing in an individual with CMS has been reported [<a class="bk_pop" href="#cms.REF.croxen.2002b.1563">Croxen et al 2002b</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Lack of improvement of clinical symptoms with immunosuppressive therapy</div></li><li class="half_rhythm"><div class="half_rhythm">Absence of major pathology in a skeletal muscle biopsy specimen despite considerable muscle weakness</div></li><li class="half_rhythm"><div class="half_rhythm">A family history consistent with either <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance</div></li></ul><div id="cms.Testing"><h4>Testing</h4><p><b>Laboratory testing</b></p><ul><li class="half_rhythm"><div>Serum creatine kinase (CK) concentration may be normal or slightly elevated (usually not more than tenfold the normal).</div></li><li class="half_rhythm"><div>Anti-AChR and anti-MuSK antibody testing (serum) is negative.</div></li></ul><p><b>Electrophysiologic testing</b></p><ul><li class="half_rhythm"><div>Generally, individuals should be tested for a decremental EMG response of the CMAP on low-frequency (2- to 3-Hz) stimulation.</div></li><li class="half_rhythm"><div>In some cases, 2- to 3-Hz stimulation elicits no decremental response from rested non-weak muscle, but elicits a significant decremental response after five to ten minutes of stimulation at 10 Hz.</div></li><li class="half_rhythm"><div>If the amplitude of the CMAP is normal in two distal and two proximal muscles, facial muscles should be tested.</div></li><li class="half_rhythm"><div>Alternatively or in addition, a single-fiber EMG is a good determinant of a neuromuscular transmission defect.</div></li><li class="half_rhythm"><div>A single nerve stimulus may elicit a repetitive CMAP (the so-called "double response to single nerve stimulus") in individuals with endplate AChE deficiency or slow-channel CMS (SCCMS; caused by <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> variants of the genes encoding the AChR subunits that prolong the time that the AChR channel is open), or in those taking high doses of AChE inhibitors.</div></li></ul><p><b>Response to AChE inhibitors</b> may be assessed by using intravenous injection of edrophonium (Tensilon<sup>&#x000ae;</sup>), a fast-acting AChE inhibitor, or by a controlled/supervised trial of oral AChE inhibitors.</p><p>Intravenous application of edrophonium chloride (known as Tensilon<sup>&#x000ae;</sup> test) must be performed under intensive care conditions. In adults with body weight higher than 30 kilograms, an initial dose of 2.0 mg is injected over 15 seconds, followed by additional doses of 3.0 mg and 5.0 mg at intervals of 60 seconds, if necessary. In newborns and infants, dosage varies [<a class="bk_pop" href="#cms.REF.schara.2012.184">Schara et al 2012</a>]. Maximum improvement occurs within 30 seconds of the injection and persists for minutes. An objective endpoint (e.g., improvement in ptosis, extraocular muscle weakness, tongue weakness, decremental EMG response) needs to be established prior to the injection and then carefully followed.</p><p>Alternatively, a controlled/supervised trial of oral medication with AChE inhibitor is possible. This may be helpful in patients with fatigable muscle weakness but no obvious clinical symptoms (e.g., ptosis, bulbar weakness) that can be easily monitored.</p><p><b>Morphologic studies.</b> Conventional skeletal muscle biopsy and routine histochemical studies in individuals with CMS generally show no major abnormalities except for type I fiber predominance and occasionally minor myopathic changes. Note: Tubular aggregates have been described in <i>GFPT1</i>-associated limb-girdle CMS [<a class="bk_pop" href="#cms.REF.senderek.2011.162">Senderek et al 2011</a>] and dystrophic changes can be found in patients with <i>GMPPB</i> pathogenic variants [<a class="bk_pop" href="#cms.REF.belaya.2015.2493">Belaya et al 2015</a>].</p></div></div><div id="cms.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of CMS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the findings <a href="#cms.Suggestive_Findings">above</a> in combination with the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in one of the genes listed in <a class="figpopup" href="/books/NBK1168/table/cms.T.molecular_genetics_of_congenital_m/?report=objectonly" target="object" rid-figpopup="figcmsTmoleculargeneticsofcongenitalm" rid-ob="figobcmsTmoleculargeneticsofcongenitalm">Table 1a</a> and <a class="figpopup" href="/books/NBK1168/table/cms.T.molecular_genetics_congenital_myas/?report=objectonly" target="object" rid-figpopup="figcmsTmoleculargeneticscongenitalmyas" rid-ob="figobcmsTmoleculargeneticscongenitalmyas">Table 1b</a>; these genes, encoding different proteins expressed at the neuromuscular junction, are currently known to be associated with CMS [<a class="bk_pop" href="#cms.REF.hanta_.2013.561">Hanta&#x000ef; et al 2013</a>, <a class="bk_pop" href="#cms.REF.rodr_guez_cruz.2014.2234">Rodr&#x000ed;guez Cruz et al 2014</a>, <a class="bk_pop" href="#cms.REF.engel.2015.461">Engel et al 2015</a>].</p><p>Molecular testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> has been considered as first-tier testing if (1) mutation of a particular gene accounts for a large proportion of the disease (see <a class="figpopup" href="/books/NBK1168/table/cms.T.molecular_genetics_of_congenital_m/?report=objectonly" target="object" rid-figpopup="figcmsTmoleculargeneticsofcongenitalm" rid-ob="figobcmsTmoleculargeneticsofcongenitalm">Table 1a</a>) <b>or</b> (2) factors including clinical findings, laboratory findings, and ancestry indicate that mutation of a particular gene is most likely.</p><p>Sequence analysis of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> of interest is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</p><p>Some clinical clues may help the clinician pinpoint the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> most likely to be involved:</p><ul><li class="half_rhythm"><div><b>Apneas.</b> Perform <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>RAPSN</i>, <i>CHAT</i>, and <i>COLQ</i>.</div></li><li class="half_rhythm"><div><b>No response to treatment with AChE inhibitors.</b> Consider testing for pathogenic variants in <i>COLQ</i>.</div></li><li class="half_rhythm"><div><b>Double response to a single nerve stimulus.</b> Consider:</div><ul><li class="half_rhythm"><div class="half_rhythm">A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>COLQ</i>;</div><div class="half_rhythm">OR</div></li><li class="half_rhythm"><div class="half_rhythm">A slow-channel CMS with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of the genes encoding the AChR subunits (<i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, <i>CHRNE</i>).</div></li></ul></li><li class="half_rhythm"><div><b>Incremental response in CMAP amplitude following maximum voluntary contraction.</b> Consider testing for <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SYT2.</i></div></li><li class="half_rhythm"><div><b><i>Pes cavus</i> and hammer toes.</b> Consider testing for <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SYT2.</i></div></li><li class="half_rhythm"><div><b>Contractures.</b> Consider testing for <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>RAPSN</i>.</div></li><li class="half_rhythm"><div><b>Autosomal dominant family history.</b> Consider slow-channel CMS caused by pathogenic variants in the genes encoding AChR subunits: <i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, <i>CHRNE</i> or SYT2-associated CMS.</div></li></ul><p>Targeted analysis for pathogenic variants may be carried out first depending on the ethnic origin of the individual:</p><ul><li class="half_rhythm"><div><b>German</b> or <b>central/western European origin.</b>
<i>RAPSN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1168/table/cms.T.selected_rapsn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figcmsTselectedrapsnpathogenicvariants" rid-ob="figobcmsTselectedrapsnpathogenicvariants">c.264C&#x0003e;A</a> and <i>DOK7</i> pathogenic variant <a class="figpopup" href="/books/NBK1168/table/cms.T.selected_dok7_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figcmsTselecteddok7pathogenicvariants" rid-ob="figobcmsTselecteddok7pathogenicvariants">c.1124_1127dupTGCC</a></div></li><li class="half_rhythm"><div><b>Southeastern European</b> or <b>Roma origin.</b>
<i>CHRNE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1168/table/cms.T.selected_chrne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figcmsTselectedchrnepathogenicvariants" rid-ob="figobcmsTselectedchrnepathogenicvariants">c.1327delG</a></div></li><li class="half_rhythm"><div><b>From the Maghreb</b> (especially Algeria and Tunisia). <i>CHRNE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1168/table/cms.T.selected_chrne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figcmsTselectedchrnepathogenicvariants" rid-ob="figobcmsTselectedchrnepathogenicvariants">c.1353dupG</a></div></li><li class="half_rhythm"><div><b>From Spain or</b>
<b>Portugal.</b>
<i>CHRNE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1168/table/cms.T.selected_chrne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figcmsTselectedchrnepathogenicvariants" rid-ob="figobcmsTselectedchrnepathogenicvariants">c.130dupG</a></div></li></ul><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes the genes from <a class="figpopup" href="/books/NBK1168/table/cms.T.molecular_genetics_of_congenital_m/?report=objectonly" target="object" rid-figpopup="figcmsTmoleculargeneticsofcongenitalm" rid-ob="figobcmsTmoleculargeneticsofcongenitalm">Table 1a</a> and <a class="figpopup" href="/books/NBK1168/table/cms.T.molecular_genetics_congenital_myas/?report=objectonly" target="object" rid-figpopup="figcmsTmoleculargeneticscongenitalmyas" rid-ob="figobcmsTmoleculargeneticscongenitalmyas">Table 1b</a> and other genes of interest (see <a href="#cms.Differential_Diagnosis">Differential Diagnosis</a>) may be considered as first- or second-tier option; due to the genetic heterogeneity of CMS, a multigene panel using <a class="def" href="/books/n/gene/glossary/def-item/next-generation-sequencing/">next-generation sequencing</a> technologies is emerging as a first-tier test. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes the genes listed in <a class="figpopup" href="/books/NBK1168/table/cms.T.molecular_genetics_of_congenital_m/?report=objectonly" target="object" rid-figpopup="figcmsTmoleculargeneticsofcongenitalm" rid-ob="figobcmsTmoleculargeneticsofcongenitalm">Table 1a</a> and <a class="figpopup" href="/books/NBK1168/table/cms.T.molecular_genetics_congenital_myas/?report=objectonly" target="object" rid-figpopup="figcmsTmoleculargeneticscongenitalmyas" rid-ob="figobcmsTmoleculargeneticscongenitalmyas">Table 1b</a>) fails to confirm a diagnosis in an individual with features of CMS. Such testing may provide an unexpected or previously unconsidered diagnosis, such as mutation in another gene that causes a similar clinical presentation.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="cms.T.molecular_genetics_of_congenital_m" class="table"><h3><span class="label">Table 1a. </span></h3><div class="caption"><p>Molecular Genetics of Congenital Myasthenic Syndromes: Most Common Genetic Causes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1168/table/cms.T.molecular_genetics_of_congenital_m/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cms.T.molecular_genetics_of_congenital_m_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" style="text-align:left;vertical-align:middle;">% of CMS Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detected by Test Method</th></tr><tr><th headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3" id="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3" id="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHAT</i></td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4%-5%</td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHRNE</i></td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50%</td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%&#x000a0;<sup>7,&#x000a0;8,&#x000a0;9</sup></td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup>, but in single cases reported&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COLQ</i></td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10%-15%</td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DOK7</i></td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10%-15%</td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GFPT1</i></td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2%</td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RAPSN</i></td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%-20%</td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~85%&#x000a0;<sup>10</sup></td><td headers="hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_1_3 hd_h_cms.T.molecular_genetics_of_congenital_m_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Up to 15%&#x000a0;<sup>11</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Pathogenic variants of any one of the genes included in this table account for &#x0003e;1% of CMS.</p></div></dd><dt>1. </dt><dd><div id="cms.TF.1a.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="cms.TF.1a.2"><p class="no_margin">See <a href="/books/NBK1168/#cms.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="cms.TF.1a.3"><p class="no_margin">See <a href="#cms.Molecular_Genetics">Molecular Genetics</a> for information on pathogenic allelic variants detected.</p></div></dd><dt>4. </dt><dd><div id="cms.TF.1a.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="cms.TF.1a.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="cms.TF.1a.6"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>7. </dt><dd><div id="cms.TF.1a.7"><p class="no_margin">The <i>CHRNE</i> founder <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1168/table/cms.T.selected_chrne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figcmsTselectedchrnepathogenicvariants" rid-ob="figobcmsTselectedchrnepathogenicvariants">c.1327delG</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 12 is present in up to 50% of individuals of European Roma and/or southeastern European origin with CMS [<a class="bk_pop" href="#cms.REF.abicht.1999.1564">Abicht et al 1999</a>, <a class="bk_pop" href="#cms.REF.karcagi.2001.231">Karcagi et al 2001</a>].</p></div></dd><dt>8. </dt><dd><div id="cms.TF.1a.8"><p class="no_margin">The <i>CHRNE</i> founder <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1168/table/cms.T.selected_chrne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figcmsTselectedchrnepathogenicvariants" rid-ob="figobcmsTselectedchrnepathogenicvariants">c.1353dupG</a> is present in up to 20% of persons from the Maghreb (especially Algeria and Tunisia) [<a class="bk_pop" href="#cms.REF.beeson.2005.498">Beeson et al 2005</a>].</p></div></dd><dt>9. </dt><dd><div id="cms.TF.1a.9"><p class="no_margin"><a class="bk_pop" href="#cms.REF.abicht.2002.1005">Abicht et al [2002]</a></p></div></dd><dt>10. </dt><dd><div id="cms.TF.1a.10"><p class="no_margin">Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of European origin, especially those with respiratory failure, have the <a class="figpopup" href="/books/NBK1168/table/cms.T.selected_rapsn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figcmsTselectedrapsnpathogenicvariants" rid-ob="figobcmsTselectedrapsnpathogenicvariants">c.264C&#x0003e;A</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on at least one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>; about 50% are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for c.264C&#x0003e;A.</p></div></dd><dt>11. </dt><dd><div id="cms.TF.1a.11"><p class="no_margin"><a class="bk_pop" href="#cms.REF.m_ller.2004a.e104">M&#x000fc;ller et al [2004a]</a>, <a class="bk_pop" href="#cms.REF.gaudon.2010.795">Gaudon et al [2010]</a></p></div></dd></dl></div></div></div><div id="cms.T.molecular_genetics_congenital_myas" class="table"><h3><span class="label">Table 1b. </span></h3><div class="caption"><p>Molecular Genetics Congenital Myasthenic Syndromes: Less Common Genetic Causes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1168/table/cms.T.molecular_genetics_congenital_myas/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cms.T.molecular_genetics_congenital_myas_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2,&#x000a0;3,&#x000a0;4</sup></th><th id="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">% of CMS Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AGRN</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reported in 7 families [<a class="bk_pop" href="#cms.REF.huz_.2009.155">Huz&#x000e9; et al 2009</a>, <a class="bk_pop" href="#cms.REF.maselli.2012.1123">Maselli et al 2012</a>, <a class="bk_pop" href="#cms.REF.karakaya.2014">Karakaya et al 2014</a>, <a class="bk_pop" href="#cms.REF.nicole.2014.2429">Nicole et al 2014</a>]</td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG2</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cms.REF.cossins.2013.944">Cossins et al [2013]</a>, <a class="bk_pop" href="#cms.REF.monies.2014.353">Monies et al [2014]</a></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG14</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cms.REF.cossins.2013.944">Cossins et al [2013]</a></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHRNA1</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Several patients reported w/AD or AR variants [<a class="bk_pop" href="#cms.REF.croxen.1997.767">Croxen et al 1997</a>, <a class="bk_pop" href="#cms.REF.rodr_guez_cruz.2014.2234">Rodr&#x000ed;guez Cruz et al 2014</a>]</td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHRNB1</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cms.REF.quiram.1999.1403">Quiram et al [1999]</a></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHRND</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cms.REF.m_ller.2006.2784">M&#x000fc;ller et al [2006]</a></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL13A1</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cms.REF.logan.2015.878">Logan et al [2015]</a></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DPAGT1</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Several patients reported [<a class="bk_pop" href="#cms.REF.belaya.2012a.29">Belaya et al 2012a</a>, <a class="bk_pop" href="#cms.REF.belaya.2012b.193">Belaya et al 2012b</a>, <a class="bk_pop" href="#cms.REF.basiri.2013.469">Basiri et al 2013</a>, <a class="bk_pop" href="#cms.REF.selcen.2014.1822">Selcen et al 2014</a>]</td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GMPPB</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cms.REF.belaya.2015.2493">Belaya et al [2015]</a></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LAMB2</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reported in 1 individual w/concomitant renal failure [<a class="bk_pop" href="#cms.REF.maselli.2009.203">Maselli et al 2009</a>]</td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LRP4</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 CMS kinships reported [<a class="bk_pop" href="#cms.REF.ohkawara.2014.1856">Ohkawara et al 2014</a>, <a class="bk_pop" href="#cms.REF.selcen.2015.889">Selcen et al 2015</a>]</td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MUSK</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reported in 8 individuals from 3 families [<a class="bk_pop" href="#cms.REF.chevessier.2004.3229">Chevessier et al 2004</a>, <a class="bk_pop" href="#cms.REF.mihaylova.2009.1926">Mihaylova et al 2009</a>, <a class="bk_pop" href="#cms.REF.maselli.2010.2370">Maselli et al 2010</a>]</td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MYO9A</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Authors, personal observation</td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLEC</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cms.REF.forrest.2010.709">Forrest et al [2010]</a>, <a class="bk_pop" href="#cms.REF.selcen.2011.327">Selcen et al [2011]</a>, <a class="bk_pop" href="#cms.REF.fattahi.2015.60">Fattahi et al [2015]</a></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PREPL</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#cms.REF.r_gal.2014.1254">R&#x000e9;gal et al [2014]</a></td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN4A</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reported in 2 unrelated individuals [<a class="bk_pop" href="#cms.REF.tsujino.2003.7377">Tsujino et al 2003</a>, <a class="bk_pop" href="#cms.REF.habbout.2016.161">Habbout et al 2016</a>]</td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC25A1</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR variants reported in 2 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs [<a class="bk_pop" href="#cms.REF.chaouch.2014.75">Chaouch et al 2014</a>]</td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC5A7</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Authors, personal observation</td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SNAP25</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>De novo</i> AD variant in 1 patient with w/myasthenia &#x00026; multiple contractures at birth, cortical hyperexcitability, cerebellar ataxia, &#x00026; severe intellectual disability [<a class="bk_pop" href="#cms.REF.shen.2014.2247">Shen et al 2014</a>]</td></tr><tr><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SYT2</i></td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cms.T.molecular_genetics_congenital_myas_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD variants in 2 multigenerational families w/foot deformities, fatigable ocular &#x00026; lower limb weakness, &#x00026; response to modulators of acetylcholine release [<a class="bk_pop" href="#cms.REF.herrmann.2014.332">Herrmann et al 2014</a>, <a class="bk_pop" href="#cms.REF.whittaker.2015.1964">Whittaker et al 2015</a>]</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Pathogenic variants of any one of the genes listed in this table are reported in only a few families (i.e., &#x0003c;1% of CMS).</p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a></p></div></dd><dt>1. </dt><dd><div id="cms.TF.1b.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="cms.TF.1b.2"><p class="no_margin">See <a href="/books/NBK1168/#cms.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="cms.TF.1b.3"><p class="no_margin">Genes are not described in detail in Molecular Genetics, but may be included <a href="/books/NBK1168/bin/cms-less_common_genes.pdf">here</a> (pdf).</p></div></dd><dt>4. </dt><dd><div id="cms.TF.1b.4"><p class="no_margin">Other subtypes of CMS have been reported in the literature in a few kinships without identification of the underlying genetic defect [<a class="bk_pop" href="#cms.REF.engel.2015.461">Engel et al 2015</a>]. A proportion of individuals with CMS remain without molecular genetic diagnosis even after <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> studies, suggesting the involvement of additional, as-yet unidentified genes in CMS.</p></div></dd></dl></div></div></div></div></div><div id="cms.Clinical_Characteristics"><h2 id="_cms_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cms.Clinical_Description"><h3>Clinical Description</h3><p><b>Onset.</b> In the <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myasthenic syndromes (CMS), the first myasthenic symptoms occur in general early in life, usually in the first two years. Rarely, onset is in the second to third decade of life [<a class="bk_pop" href="#cms.REF.milone.1999.a188">Milone et al 1999</a>, <a class="bk_pop" href="#cms.REF.croxen.2002a.162">Croxen et al 2002a</a>, <a class="bk_pop" href="#cms.REF.burke.2003.826">Burke et al 2003</a>, <a class="bk_pop" href="#cms.REF.m_ller.2007a.1497">M&#x000fc;ller et al 2007a</a>, <a class="bk_pop" href="#cms.REF.croxen.2009.294">Croxen et al 2009</a>, <a class="bk_pop" href="#cms.REF.ben_ammar.2010.754">Ben Ammar et al 2010</a>, <a class="bk_pop" href="#cms.REF.guergueltcheva.2012.838">Guergueltcheva et al 2012</a>].</p><p><b>Neuromuscular findings.</b> CMS is limited to weakness of the skeletal muscles. Cardiac and smooth muscle are usually not involved. Coordination, sensation, and tendon reflexes are normal; cognitive skills are usually normal.</p><p><b>Neonatal presentation.</b> Some myasthenic symptoms are present at birth.</p><ul><li class="half_rhythm"><div>Respiratory insufficiency with sudden apnea and cyanosis are common findings in neonates.</div></li><li class="half_rhythm"><div>Neonates with CMS can have multiple joint contractures (often described as arthrogryposis multiplex congenita [AMC]) resulting from a lack of fetal movement in utero.</div></li><li class="half_rhythm"><div>Other major findings in the neonatal period may include feeding difficulties, poor suck and cry, choking spells, eyelid ptosis, and facial, bulbar, and generalized weakness. Stridor in infancy may be an important clue to CMS [<a class="bk_pop" href="#cms.REF.kinali.2008.6">Kinali et al 2008</a>].</div></li></ul><p><b>Childhood presentation.</b> Individuals with onset later in childhood show abnormal muscle fatigability, with difficulty in running or climbing stairs.</p><ul><li class="half_rhythm"><div>Motor milestones may be delayed.</div></li><li class="half_rhythm"><div>Affected individuals present with fluctuating eyelid ptosis and fixed or fluctuating extraocular muscle weakness. Ptosis may involve one or both eyelids.</div></li><li class="half_rhythm"><div>In addition, facial and bulbar weakness with nasal speech and difficulties in coughing and swallowing may be present.</div></li><li class="half_rhythm"><div>Spinal deformity or muscle atrophy may occur.</div></li></ul><p><b>Limb-girdle presentation.</b> Some individuals display a characteristic "limb-girdle" pattern of weakness with ptosis and a waddling gait, with or without ptosis and ophthalmoparesis ("limb-girdle myasthenia").</p><p><b>Dysmorphic features.</b> In some individuals, long face, narrow jaw, and a high-arched palate have been reported [<a class="bk_pop" href="#cms.REF.burke.2004.356">Burke et al 2004</a>].</p><p><b>Cognitive skills.</b> The vast majority of individuals with CMS have normal cognitive skills. Recently, three patients have been reported with <i>DPAGT1</i>-associated CMS and intellectual disability [<a class="bk_pop" href="#cms.REF.selcen.2014.1822">Selcen et al 2014</a>]. Severe intellectual disability appears to be a feature of <i>SNAP25-</i>associated CMS [<a class="bk_pop" href="#cms.REF.shen.2014.2247">Shen et al 2014</a>].</p><p><b>Prognosis.</b> Severity and course of disease are highly variable, ranging from minor symptoms (e.g., mild exercise intolerance) to progressive disabling weakness. Minor myasthenic symptoms may be exacerbated by sudden onset of severe weakness or respiratory insufficiency precipitated by fever, infections, or excitement especially in individuals with CMS with episodic apnea (CMS-EA) or endplate rapsyn deficiency [<a class="bk_pop" href="#cms.REF.ohno.2001.2017">Ohno et al 2001</a>, <a class="bk_pop" href="#cms.REF.byring.2002.548">Byring et al 2002</a>, <a class="bk_pop" href="#cms.REF.ohno.2002.875">Ohno et al 2002</a>].</p></div><div id="cms.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p>Major CMS subtypes are recognized based on molecular genetic studies [<a class="bk_pop" href="#cms.REF.finlayson.2013.80">Finlayson et al 2013</a>, <a class="bk_pop" href="#cms.REF.engel.2015.461">Engel et al 2015</a>] (see <a class="figpopup" href="/books/NBK1168/table/cms.T.cms_subtypes_by_gene_involved/?report=objectonly" target="object" rid-figpopup="figcmsTcmssubtypesbygeneinvolved" rid-ob="figobcmsTcmssubtypesbygeneinvolved">Table 2</a>).</p><div id="cms.T.cms_subtypes_by_gene_involved" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>CMS Subtypes by Gene Involved</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1168/table/cms.T.cms_subtypes_by_gene_involved/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cms.T.cms_subtypes_by_gene_involved_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s) Associated with Disease</th><th id="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CMS Subtype</th><th id="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Findings&#x000a0;<sup>1</sup></th><th id="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Response to AChE Inhibitors&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHAT</i></td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CMS w/episodic apnea</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypotonia, respiratory failure at birth</div></li><li class="half_rhythm"><div>Episodic apnea</div></li><li class="half_rhythm"><div>Improvement w/age</div></li></ul>
</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Improvement</td></tr><tr><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">AChR subunit genes:
<ul><li class="half_rhythm"><div><i>CHRNE</i></div></li><li class="half_rhythm"><div><i>CHRNA1</i></div></li><li class="half_rhythm"><div><i>CHRNB1</i></div></li><li class="half_rhythm"><div><i>CHRND</i></div></li></ul>
</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Acetylcholine receptor deficiency</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Early onset</div></li><li class="half_rhythm"><div>Varies from mild to severe</div></li><li class="half_rhythm"><div>Ptosis, EOP;&#x000a0;<sup>3</sup> bulbar, arm, leg weakness</div></li></ul>
</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Improvement</td></tr><tr><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Slow-channel CMS</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Selective severe neck, wrist, finger extensor weakness</div></li><li class="half_rhythm"><div>Childhood to adult onset</div></li><li class="half_rhythm"><div>Varies from mild to severe</div></li><li class="half_rhythm"><div>Progressive ventilatory insufficiency; may require assisted ventilation</div></li></ul>
</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Often deterioration</td></tr><tr><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Fast-channel CMS</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Varies from mild to severe</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Improvement</td></tr><tr><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COLQ</i></td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Endplate AChE deficiency</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Often severe</div></li><li class="half_rhythm"><div>In some w/C-terminal <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants: later presentation, milder clinical course</div></li><li class="half_rhythm"><div>EOP</div></li><li class="half_rhythm"><div>General muscle weakness / severe involvement of axial muscles</div></li><li class="half_rhythm"><div>Slow pupillary light response</div></li></ul>
</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deterioration or no response</td></tr><tr><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DOK7</i></td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DOK7-associated limb-girdle-myasthenia</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Limb-girdle pattern of weakness w/predominantly proximal weakness, waddling gait, &#x00026; ptosis but no EOP</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deterioration or no response</td></tr><tr><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RAPSN</i></td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Endplate rapsyn deficiency</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early onset:
<ul><li class="half_rhythm"><div>Hypotonia, respiratory failure at birth</div></li><li class="half_rhythm"><div>Episodic apnea</div></li><li class="half_rhythm"><div>Arthrogryposis multiplex congenita</div></li><li class="half_rhythm"><div>Varies from mild to severe</div></li></ul>
Late onset:
<ul><li class="half_rhythm"><div>Limb weakness in adolescence or adulthood resembling seronegative myasthenia gravis</div></li></ul>
</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Improvement</td></tr><tr><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GFPT1</i>, <i>DPAGT1</i>, <i>ALG2</i>, <i>ALG14</i>, <i>GMPPB</i>, <i>PREPL</i></td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Limb-girdle-myasthenia w/glycosylation deficiency</td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">"Limb-girdle" pattern of weakness w/predominantly proximal weakness but usually no ptosis or EOP; sometimes tubular aggregates in muscle biopsy&#x000a0;<sup>4</sup></td><td headers="hd_h_cms.T.cms_subtypes_by_gene_involved_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Improvement</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Includes only those genes for which more than a few individuals/families have been reported</p></div></dd><dt>1. </dt><dd><div id="cms.TF.2.1"><p class="no_margin">Because of the many <a class="def" href="/books/n/gene/glossary/def-item/private/">private</a> pathogenic variants and the limited number of <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>, the clinical spectrum may be broader or different from the findings listed.</p></div></dd><dt>2. </dt><dd><div id="cms.TF.2.2"><p class="no_margin">See Diagnosis, <a href="#cms.Testing">Testing</a>, <b>Response to acetylcholinesterase inhibitors</b>.</p></div></dd><dt>3. </dt><dd><div id="cms.TF.2.3"><p class="no_margin">EOP = external ophthalmoplegia</p></div></dd><dt>4. </dt><dd><div id="cms.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#cms.REF.senderek.2011.162">Senderek et al [2011]</a>, <a class="bk_pop" href="#cms.REF.guergueltcheva.2012.838">Guergueltcheva et al [2012]</a></p></div></dd></dl></div></div></div></div><div id="cms.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Pathogenic variants in the genes encoding the AChR subunits (<i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, <i>CHRNE</i>) can be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><ul><li class="half_rhythm"><div>Gain-of-function variants in <i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, or <i>CHRNE</i> that alter the kinetic properties of the AChR result in the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> slow-channel CMS (SCCMS) [<a class="bk_pop" href="#cms.REF.engel.2003.339">Engel et al 2003</a>].</div></li><li class="half_rhythm"><div>Loss-of-function variants in the AChR subunit genes (<i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, <i>CHRNE</i>) are associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> CMS [<a class="bk_pop" href="#cms.REF.hanta_.2004.539">Hanta&#x000ef; et al 2004</a>, <a class="bk_pop" href="#cms.REF.ohno.2004a.117">Ohno &#x00026; Engel 2004a</a>, <a class="bk_pop" href="#cms.REF.engel.2005.308">Engel &#x00026; Sine 2005</a>].</div></li><li class="half_rhythm"><div>Some clinical clues point to specific genetic defects [<a class="bk_pop" href="#cms.REF.abicht.2012.1474">Abicht et al 2012</a>, <a class="bk_pop" href="#cms.REF.finlayson.2013.80">Finlayson et al 2013</a>, <a class="bk_pop" href="#cms.REF.engel.2015.461">Engel et al 2015</a>]. For example, arthrogryposis multiplex congenita [AMC]) appears to be particularly common in infants with truncating <i>RAPSN</i> pathogenic variants [<a class="bk_pop" href="#cms.REF.brownlow.2001.125">Brownlow et al 2001</a>, <a class="bk_pop" href="#cms.REF.burke.2003.826">Burke et al 2003</a>, <a class="bk_pop" href="#cms.REF.beeson.2005.498">Beeson et al 2005</a>]. Stridor in infancy may occur in CMS, particularly in those with <i>DOK7</i> pathogenic variants [<a class="bk_pop" href="#cms.REF.kinali.2008.6">Kinali et al 2008</a>]. See <a class="figpopup" href="/books/NBK1168/table/cms.T.cms_subtypes_by_gene_involved/?report=objectonly" target="object" rid-figpopup="figcmsTcmssubtypesbygeneinvolved" rid-ob="figobcmsTcmssubtypesbygeneinvolved">Table 2</a> and <a href="#cms.Establishing_the_Diagnosis">Establishing the Diagnosis</a>.</div></li></ul><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations are difficult to establish for those rare CMS subtypes for which pathogenic variants have been identified in only a few patients worldwide.</p></div><div id="cms.Penetrance"><h3>Penetrance</h3><p>In general, reported CMS pathogenic variants have complete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p><p>One case of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> has been reported for slow-channel CMS (SCCMS) resulting from pathogenic variants in <i>CHRNE</i> [<a class="bk_pop" href="#cms.REF.croxen.2002a.162">Croxen et al 2002a</a>, <a class="bk_pop" href="#cms.REF.croxen.2009.294">Croxen et al 2009</a>].</p></div><div id="cms.Nomenclature"><h3>Nomenclature</h3><p>An outdated and misleading term is "<a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile myasthenia" (FIM) [<a class="bk_pop" href="#cms.REF.deymeer.1999.129">Deymeer et al 1999</a>].</p></div><div id="cms.Prevalence"><h3>Prevalence</h3><p>The prevalence of CMS is estimated at one tenth that of myasthenia gravis (which has a prevalence of 25:1,000,000-125:1,000,000); however, it may be higher. At least 1,000 independent kinships with identified pathogenic variants have been documented worldwide [<a class="bk_pop" href="#cms.REF.chaouch.2012b.474">Chaouch et al 2012b</a>].</p><p>The population of the southeastern European Roma may be at higher risk for CMS because of an increased <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> (&#x0003e;4%) for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1168/table/cms.T.selected_chrne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figcmsTselectedchrnepathogenicvariants" rid-ob="figobcmsTselectedchrnepathogenicvariants">c.1327delG</a> in <i>CHRNE</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding the &#x003b5;AChR subunit [<a class="bk_pop" href="#cms.REF.morar.2004.596">Morar et al 2004</a>].</p><p>Individuals from the Maghreb (especially Algeria and Tunisia) may be at higher risk for CMS because of another <i>CHRNE</i> founder <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, <a class="figpopup" href="/books/NBK1168/table/cms.T.selected_chrne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figcmsTselectedchrnepathogenicvariants" rid-ob="figobcmsTselectedchrnepathogenicvariants">c.1353dupG</a> [<a class="bk_pop" href="#cms.REF.beeson.2005.498">Beeson et al 2005</a>].</p></div></div><div id="cms.Genetically_Related_Allelic_Disorder"><h2 id="_cms_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p><b><i>SCN4A.</i></b> Gain-of-function variants in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (encoding the sodium channel protein type 4 subunit alpha) have been identified in several disorders of muscle membrane excitability: potassium-aggravated myotonia, paramyotonia congenita, and <a href="/books/n/gene/hyper-pp/">hyperkalemic periodic paralysis</a> [<a class="bk_pop" href="#cms.REF.jurkatrott.2010.239">Jurkat-Rott et al 2010</a>].</p><p><b>Fetal akinesia deformation sequence (FADS), prenatal CMS.</b> Fetal hypomobility can result in the intrauterine <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of FADS, characterized by severe joint contractures, subcutaneous edema, growth retardation, lung hypoplasia, and other malformations. FADS has multiple etiologies and can be lethal or non-lethal. If multiple pterygia are present the phenotype is described as Escobar syndrome and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants have been identified in the fetally expressed gamma subunit of AChR (<i>CHRNG</i>) [<a class="bk_pop" href="#cms.REF.ravenscroft.2011.793">Ravenscroft et al 2011</a>]. For several CMS-related genes it has been demonstrated that biallelic variants with most severe functional effects (mainly <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> variants) result in the phenotype of FADS ("prenatal CMS"). So far, a FADS phenotype has been reported for variants in <i>RAPSN</i>, <i>DOK7</i>, <i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, <i>MUSK</i>, and <i>DPAGT1</i> [<a class="bk_pop" href="#cms.REF.vogt.2008.222">Vogt et al 2008</a>, <a class="bk_pop" href="#cms.REF.ravenscroft.2011.793">Ravenscroft et al 2011</a>, <a class="bk_pop" href="#cms.REF.ganetzky.2015.2411">Ganetzky et al 2015</a>, <a class="bk_pop" href="#cms.REF.tansindhunata.2015.1151">Tan-Sindhunata et al 2015</a>].</p><p><a href="/books/n/gene/cdg/"><b>Congenital disorders of glycosylation</b></a>
<b>(CDG)</b> are a genetically heterogeneous etiology for individuals with complex neurogenetic malformations and <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features. Pathogenic variants in <i>DPAGT1</i> and <i>ALG2</i> have also been shown to be causative for <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> CDG (DPAGT1-CDG [<i>CDG-Ij</i>] and ALG2-CDG [<i>CDG-Ii</i>]). The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of individuals with DPAGT1-CDG may show some clinical overlap especially in most severe/prenatal CMS [<a class="bk_pop" href="#cms.REF.ganetzky.2015.2411">Ganetzky et al 2015</a>].</p><p>Pathogenic variants in <i>GMPPB</i>, another CMS-related <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> of the glycosylation pathway, have also been reported to lead to the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of muscular dystrophy-dystroglycanopathy.</p><p><b>Pierson syndrome</b> is mainly characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> nephrotic syndrome, diffuse mesangial sclerosis, and distinct ocular abnormalities including microcoria. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children exhibit early onset of chronic renal failure, neurodevelopmental deficits, and blindness. It is a rare <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder caused by pathogenic variants in <i>LAMB2</i>. CMS associated with <i>LAMB2</i> pathogenic variants has to date been documented exclusively in a patient with additional renal symptoms [<a class="bk_pop" href="#cms.REF.maselli.2009.203">Maselli et al 2009</a>].</p></div><div id="cms.Differential_Diagnosis"><h2 id="_cms_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Myasthenia gravis</b> (OMIM <a href="http://omim.org/entry/254200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">254200</a>). The clinical picture of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myasthenic syndromes (CMS) is similar to that of myasthenia gravis (MG), in which individuals have a history of fatigable weakness involving ocular, bulbar, and limb muscles; however, the myasthenic symptoms of CMS usually start at or shortly after birth rather than in adulthood, as is usual for MG. Because seronegative autoimmune MG has been reported on occasion in children younger than age two years, MG may be difficult to differentiate from CMS, especially in later childhood or adulthood. Furthermore, immunosuppressive therapy does not improve clinical symptoms in CMS, whereas it does in MG.</p><p><b>Transient neonatal myasthenia gravis.</b> Autoimmune MG can be passed across the placenta from mother to fetus and so can affect offspring at birth.</p><p><b>Childhood.</b> Other disorders partially resembling CMS to consider:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/sma/">Spinal muscular atrophy</a></div></li><li class="half_rhythm"><div>Spinal muscular atrophy with respiratory distress 1 (SMARD1) (OMIM <a href="http://omim.org/entry/604320" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">604320</a>)</div></li><li class="half_rhythm"><div>Congenital muscular dystrophies</div></li><li class="half_rhythm"><div>Congenital myopathies including <a href="/books/n/gene/mtm/">X-linked myotubular myopathy</a>, nemaline myopathy (OMIM <a href="https://omim.org/phenotypicSeries/PS161800" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS161800</a>), and multiminicore myopathy (OMIM <a href="https://omim.org/entry/606210" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606210</a>, <a href="https://omim.org/entry/180901" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">180901</a>)</div></li><li class="half_rhythm"><div>Infantile <a href="/books/n/gene/myotonic-d/">myotonic dystrophy type 1</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/mt-overview/">Mitochondrial myopathies</a></div></li><li class="half_rhythm"><div>Brain stem anomalies</div></li><li class="half_rhythm"><div>Mobius syndrome (OMIM <a href="http://omim.org/entry/157900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">157900</a>)</div></li><li class="half_rhythm"><div>Infantile botulism</div></li></ul><p><b>Adulthood.</b> Other disorders partially resembling CMS to consider:</p><ul><li class="half_rhythm"><div>Motor neuron disease including <a href="/books/n/gene/kennedy/">spinal and bulbar muscular atrophy</a> (SBMA, Kennedy disease)</div></li><li class="half_rhythm"><div>Limb-girdle muscular dystrophy</div></li><li class="half_rhythm"><div><a href="/books/n/gene/fsh/">Facioscapulohumeral dystrophy</a></div></li><li class="half_rhythm"><div>Mitochondrial myopathy and chronic progressive external ophthalmoplegia (CPEO) (see <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>)</div></li><li class="half_rhythm"><div>Autosomal dominant progressive external ophthalmoplegia (ADPEO); caused by pathogenic variants in <i>SLC25A4</i> (OMIM <a href="http://omim.org/entry/609283" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609283</a>), <i>TWNK</i> (<i>C10orf2</i>) (OMIM <a href="http://omim.org/entry/609286" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609286</a>)<i>,</i> or <a href="/books/n/gene/alpers/"><i>POLG</i></a></div></li></ul></div><div id="cms.Management"><h2 id="_cms_Management_">Management</h2><div id="cms.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myasthenic syndromes (CMS), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Neurologic/neuropediatric examination. Assessment of strength and motor function; in children, assessment of motor, speech, and cognitive development</div></li><li class="half_rhythm"><div>Respiratory care. Assessment of respiratory function with baseline pulmonary function tests including forced vital capacity in sitting and supine positions and blood gas exchange. Polysomnography to identify individuals with nocturnal hypoventilation. Symptoms of hypercapnea that should be discussed: daytime headache, restless sleep, loss of concentration, snoring, recurrent respiratory infections, and weight loss. Respiratory studies may be normal between episodes in patients who experience acute crises.</div></li><li class="half_rhythm"><div>Assessment of contractures and joint deformities by physiatrists and orthopedists; radiologic examinations if spinal deformity is observed</div></li><li class="half_rhythm"><div>Speech therapy evaluation if dysarthria and/or hypernasal speech is present</div></li><li class="half_rhythm"><div>For early-onset forms, assessment of feeding abilities (sucking, swallowing, gastroesophageal reflux) and growth parameters to determine the need for feeding interventions such as gavage feeding or gastrostomy insertion</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="cms.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>There are no recent published consensus guidelines for the management of CMS treatment.</p><div id="cms.Medical_Treatment"><h4>Medical Treatment</h4><p>The choice of medical treatment varies with the CMS subtype [<a class="bk_pop" href="#cms.REF.schara.2012.184">Schara et al 2012</a>, <a class="bk_pop" href="#cms.REF.finlayson.2013.80">Finlayson et al 2013</a>]. Therefore, it seems reasonable to consider a first-line genetic test to evaluate the genetic subtype. However, there may be individual clinical situations demanding an immediate therapeutic trial. Monotherapy is the usual course of treatment for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myasthenia; however, a combination of drugs may be necessary to optimize the therapeutic effect and to minimize side effects.</p><p><b>Acetylcholineesterase (AChE) inhibitors (pyridostigmine).</b> Although the majority of individuals with CMS benefit from AChE inhibitors (pyridostigmine), some myasthenic symptoms may remain refractory to treatment even in individuals who are otherwise responsive. Certain CMS subtypes (see <a class="figpopup" href="/books/NBK1168/table/cms.T.cms_subtypes_by_gene_involved/?report=objectonly" target="object" rid-figpopup="figcmsTcmssubtypesbygeneinvolved" rid-ob="figobcmsTcmssubtypesbygeneinvolved">Table 2</a>), including endplate (EP) AChE deficiency, slow-channel CMS (SCCMS), and <i>DOK7</i>-related CMS, are refractory to or deteriorate with AChE inhibitors [<a class="bk_pop" href="#cms.REF.schara.2012.184">Schara et al 2012</a>, <a class="bk_pop" href="#cms.REF.finlayson.2013.80">Finlayson et al 2013</a>].</p><p><b>3,4-diaminopyridine (3,4-DAP).</b> Alternatively or in addition to AChE inhibitors, the potassium channel blocker 3,4-DAP may be used [<a class="bk_pop" href="#cms.REF.schara.2012.184">Schara et al 2012</a>, <a class="bk_pop" href="#cms.REF.finlayson.2013.80">Finlayson et al 2013</a>]. This drug increases the release of ACh and prolongs the presynaptic action potential. Of note, two children with fast-channel CMS (FCCMS; caused by <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants of the genes encoding the acetylcholine receptor (AChR) subunits that shorten the time that the AChR channel is open) died when started on 3,4-DAP [<a class="bk_pop" href="#cms.REF.beeson.2005.498">Beeson et al 2005</a>]. Although a relation to 3,4-DAP has not been proven, clinicians must be cautious when using 3,4-DAP in young children and in individuals with FCCMS.</p><p><b>Ephedrine</b> treatment shows positive effects in different subtypes of CMS [<a class="bk_pop" href="#cms.REF.schara.2012.184">Schara et al 2012</a>, <a class="bk_pop" href="#cms.REF.finlayson.2013.80">Finlayson et al 2013</a>, <a class="bk_pop" href="#cms.REF.vrinten.2014.cd010028">Vrinten et al 2014</a>] and may be an alternative treatment option for CMS subtypes that are refractory to AChE inhibitors, such as <i>COLQ-</i> and <i>DOK7</i>-associated CMS [<a class="bk_pop" href="#cms.REF.bestuecardiel.2005.144">Bestue-Cardiel et al 2005</a>, <a class="bk_pop" href="#cms.REF.schara.2009.828">Schara et al 2009</a>, <a class="bk_pop" href="#cms.REF.lashley.2010.1517">Lashley et al 2010</a>, <a class="bk_pop" href="#cms.REF.witting.2014.350">Witting &#x00026; Vissing 2014</a>]. It is well tolerated by most patients and improvement in strength can be profound.</p><p><b>Albuterol,</b> an alternative to ephedrine, may have a role in the treatment of <i>COLQ-</i> and <i>DOK7</i>-associated CMS [<a class="bk_pop" href="#cms.REF.liewluck.2011.789">Liewluck et al 2011</a>, <a class="bk_pop" href="#cms.REF.burke.2013.170">Burke et al 2013</a>, <a class="bk_pop" href="#cms.REF.lorenzoni.2013.155">Lorenzoni et al 2013</a>, <a class="bk_pop" href="#cms.REF.witting.2014.350">Witting &#x00026; Vissing 2014</a>].</p><p><b>Quinidine, fluoxetine.</b> Some individuals with genetically defined SCCMS (caused by <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> variants of the genes encoding the AChR subunits that prolong the time that the AChR channel is open) have been successfully treated with quinidine, a long-lived open-channel blocker of AChR [<a class="bk_pop" href="#cms.REF.harper.1998.480">Harper &#x00026; Engel 1998</a>]. Quinidine in turn may be detrimental in individuals with AChR deficiency.</p><p>The therapeutic benefit of fluoxetine in SCCMS has been shown [<a class="bk_pop" href="#cms.REF.harper.2003.1710">Harper et al 2003</a>, <a class="bk_pop" href="#cms.REF.colomer.2006.329">Colomer et al 2006</a>]; however, it may induce suicidal ideation; thus, caution is strongly suggested in its use in childhood [<a class="bk_pop" href="#cms.REF.engel.2007.252">Engel 2007</a>].</p><p>Overall fluoxetine appears to be the accepted first-line treatment in SCCMS, whereas quinidine is the treatment of choice in children and teenagers because of the risk of psychiatric side effects associated with fluoxetine [<a class="bk_pop" href="#cms.REF.chaouch.2012a.566">Chaouch et al 2012a</a>, <a class="bk_pop" href="#cms.REF.chaouch.2012b.474">Chaouch et al 2012b</a>].</p></div><div id="cms.NonMedical_Treatment"><h4>Non-Medical Treatment</h4><p>In addition to medical therapy, a multidisciplinary approach to the clinical management of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual greatly improves quality of life and can influence survival. Management should be tailored to each individual, their specific CMS subtype, and rate of progression.</p><p>Depending on the individual clinical situation the clinical management may include the following:</p><ul><li class="half_rhythm"><div>Physical and occupational therapy</div></li><li class="half_rhythm"><div>Speech therapy</div></li><li class="half_rhythm"><div>Orthotics or a wheelchair</div></li><li class="half_rhythm"><div>A percutaneous gastric tube</div></li><li class="half_rhythm"><div>Ventilatory support</div></li></ul></div></div><div id="cms.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p>Sudden respiratory insufficiency or apneic attacks provoked by fever or infections are common in individuals with pathogenic variants in <i>CHAT</i> or <i>RAPSN</i>, even if the myasthenic symptoms are mild between crises. These individuals should receive prophylactic anticholinesterase therapy. Note: Less frequently, acute respiratory events may also occur in other CMS subtypes. Parents of infants are advised to use apnea monitors and be trained in CPR.</p></div><div id="cms.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Side effects of drugs used to treat myasthenic symptoms should be carefully monitored. If necessary, individual doses should be adjusted or treatment should be stopped. For example, quinidine has some major side effects including <i>torsades de pointes</i> (a potentially life-threatening arrhythmia), hypotension, cinchonism (or quininism), and hypersensitivity reactions. In individuals with CMS, adverse effects including exacerbation of weakness and development of respiratory failure may occur.</p></div><div id="cms.Surveillance"><h3>Surveillance</h3><p>Routine surveillance of muscle strength and respiratory function is recommended. In some patients, especially those with <i>COLQ</i> and <i>DOK7</i> pathogenic variants, slowly progressive respiratory impairment is seen with increasing age. Symptoms of nighttime hypoventilation should be considered.</p></div><div id="cms.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>A number of drugs are known to affect neuromuscular transmission and therefore exacerbate symptoms of myasthenia gravis (e.g., ciprofloxacin, chloroquine, procaine, lithium, phenytoin, beta-blockers, procainamide, and quinidine). These drugs are not absolutely contraindicated and may be used with caution in CMS. See <a href="https://myasthenia.org/What-is-MG/MG-Management/Cautionary-Drugs" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myasthenia Gravis: Cautionary Drugs</a> for a more complete list.</p></div><div id="cms.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic at-risk relatives of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures, especially newborns or young children, who could benefit from early treatment to prevent sudden respiratory failure.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known;</div></li><li class="half_rhythm"><div>Neurologic/neuropediatric examination, electrophysiologic testing (repetitive nerve stimulation) if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known.</div></li></ul><p>See <a href="#cms.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cms.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Data on pregnancies in CMS are limited. Seventeen pregnancies were reported in eight French patients with CMS [<a class="bk_pop" href="#cms.REF.servais.2013.815">Servais et al 2013</a>]. According to these data pregnancy was a frequent cause of clinical exacerbation but the vast majority of patients recovered their pre-pregnancy clinical status six months after delivery. The children's outcome was excellent, except for one newborn who developed a severe, neonatal (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>) slow-channel CMS. Pregnant patients should be closely followed by neurologists during the course of pregnancy. Careful respiratory and cardiac surveillance should be initiated in consultation with obstetric specialists.</p></div><div id="cms.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="cms.Genetic_Counseling"><h2 id="_cms_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cms.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Congenital myasthenic syndrome (CMS) caused by mutation of <i>AGRN</i>, <i>ALG14</i>, <i>ALG2</i>, <i>CHAT</i>, <i>COL13A1</i>, <i>COLQ</i>, <i>DOK7</i>, <i>DPAGT1</i>, <i>GFPT1</i>, <i>GMPPB</i>, <i>LAMB2</i>, <i>LRP4</i>, <i>MUSK</i>, <i>MYO9A</i>, <i>PLEC</i>, <i>PREPL</i>, <i>RAPSN</i>, <i>SCN4A</i>, and <i>SLC25A1</i> is always inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p>CMS caused by mutation of <i>SYT2</i> and <i>SLC5A7</i> is inherited in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p><i>SNAP25-</i>related CMS has been described as the result of an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p>CMS associated with pathogenic variants in the genes encoding the AChR subunits (<i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, and <i>CHRNE</i>) can be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><ul><li class="half_rhythm"><div>Gain-of-function variants in <i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, and <i>CHRNE</i> that alter the kinetic properties of the AChR result in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> slow-channel CMS.</div></li><li class="half_rhythm"><div>Loss-of-function variants in the AChR subunit genes (<i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, and <i>CHRNE</i>) are associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> CMS [<a class="bk_pop" href="#cms.REF.hanta_.2004.539">Hanta&#x000ef; et al 2004</a>, <a class="bk_pop" href="#cms.REF.ohno.2004a.117">Ohno &#x00026; Engel 2004a</a>, <a class="bk_pop" href="#cms.REF.engel.2005.308">Engel &#x00026; Sine 2005</a>].</div></li></ul></div><div id="cms.Risk_to_Family_Members__Autosomal_Re"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of a child with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myasthenic syndrome (AR-CMS) are obligate heterozygotes (i.e., carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are clinically asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are clinically asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with AR-CMS are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>The risk that the offspring will inherit a second CMS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> depends on the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s reproductive partner.</div></li><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency of CMS-related pathogenic variants in the general population is low.</div></li><li class="half_rhythm"><div>In populations with a high <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> and/or a high rate of <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> marriages, the risk to the offspring of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual of being affected is increased (see <a href="#cms.Prevalence">Prevalence</a>).</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a CMS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Carrier (Heterozygote) Detection</b></p><p>Carrier testing for at-risk relatives requires prior identification of the CMS-related pathogenic variants in the family.</p></div><div id="cms.Risk_to_Family_Members__Autosomal_Do"><h3>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myasthenic syndrome (AD-CMS) have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an AD-CMS may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by a <i>de novo</i> pathogenic variant is unknown.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, two possible explanations are a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk of inheriting the variant is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected and the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to the sibs of a proband is low but greater than in the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with AD-CMS has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has a CMS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p></div><div id="cms.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#cms.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk, are carriers, or are at risk of being carriers.</div></li></ul><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cms.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the CMS-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for CMS are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cms.Resources"><h2 id="_cms_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Myasthenia Gravis Foundation of America, Inc. (MGFA)</b></div><div>355 Lexington Avenue</div><div>15th Floor</div><div>New York NY 10017</div><div><b>Phone:</b> 800-541-5454 (toll-free); 212-297-2156</div><div><b>Fax:</b> 212-370-9047</div><div><b>Email:</b> mgfa@myasthenia.org</div><div><a href="http://www.myasthenia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.myasthenia.org</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Congenital-Myasthenia-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Congenital Myasthenia Information Page</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li></ul></div><div id="cms.Molecular_Genetics"><h2 id="_cms_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cms.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Congenital Myasthenic Syndromes: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1168/table/cms.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cms.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/375790" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>AGRN</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=375790" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p36<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O00468" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Agrin</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/AGRN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AGRN homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=AGRN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AGRN</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=AGRN[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AGRN</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/85365" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ALG2</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=85365" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q22<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9H553" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alpha-1,3/1,6-mannosyltransferase ALG2</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ALG2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALG2 database</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ALG2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALG2</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ALG2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALG2</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/199857" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ALG14</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=199857" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p21<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96F25" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UDP-N-acetylglucosamine transferase subunit ALG14 homolog</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ALG14" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALG14</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ALG14[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALG14</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1103" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHAT</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1103" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q11<wbr style="display:inline-block"></wbr>​.23</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P28329" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Choline O-acetyltransferase</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/CHAT" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHAT homepage - Leiden Muscular Dystrophy pages</a><br /><a href="https://databases.lovd.nl/shared/genes/CHAT" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHAT @ LOVD</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHAT" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHAT</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHAT[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHAT</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1134" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHRNA1</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1134" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q31<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P02708" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Acetylcholine receptor subunit alpha</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CHRNA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNA1 database</a><br /><a href="https://databases.lovd.nl/shared/genes/CHRNA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNA1 homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHRNA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNA1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHRNA1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNA1</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1140" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHRNB1</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1140" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17p13<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P11230" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Acetylcholine receptor subunit beta</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CHRNB1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNB1 database</a><br /><a href="https://databases.lovd.nl/shared/genes/CHRNB1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNB1 homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHRNB1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNB1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHRNB1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNB1</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1144" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHRND</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1144" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q37<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q07001" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Acetylcholine receptor subunit delta</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/CHRND" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Leiden Muscular Dystrophy pages (CHRND)</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHRND" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRND</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHRND[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRND</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1145" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CHRNE</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1145" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17p13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q04844" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Acetylcholine receptor subunit epsilon</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/CHRNE" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNE homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CHRNE" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNE</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CHRNE[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CHRNE</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1305" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COL13A1</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1305" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q22<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q5TAT6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Collagen alpha-1(XIII) chain</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COL13A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL13A1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COL13A1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL13A1</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8292" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COLQ</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8292" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p25<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y215" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Acetylcholinesterase collagenic tail peptide</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://bioweb.ensam.inra.fr/esther" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ESTHER www server: ESTerases and alpha/beta Hydrolase Enzymes and Relatives (COLQ)</a><br /><a href="https://databases.lovd.nl/shared/genes/COLQ" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COLQ homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COLQ" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COLQ</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COLQ[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COLQ</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/285489" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>DOK7</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=285489" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">4p16<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q18PE1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Protein Dok-7</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/DOK7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DOK7 homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=DOK7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DOK7</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=DOK7[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DOK7</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1798" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>DPAGT1</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1798" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q23<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9H3H5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/DPAGT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DPAGT1 database</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=DPAGT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DPAGT1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=DPAGT1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DPAGT1</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2673" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GFPT1</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2673" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2p13<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q06210" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/GFPT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GFPT1 homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GFPT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GFPT1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GFPT1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GFPT1</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/29925" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GMPPB</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=29925" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p21<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y5P6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mannose-1-phosphate guanyltransferase beta</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/GMPPB" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GMPPB homepage</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GMPPB" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GMPPB</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GMPPB[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GMPPB</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3913" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>LAMB2</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3913" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p21<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P55268" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Laminin subunit beta-2</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/LAMB2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LAMB2 database</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=LAMB2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LAMB2</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=LAMB2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LAMB2</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4038" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>LRP4</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4038" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p11<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O75096" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Low-density lipoprotein receptor-related protein 4</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/LRP4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LRP4 database</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=LRP4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LRP4</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=LRP4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LRP4</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4593" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MUSK</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4593" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q31<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O15146" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Muscle, skeletal receptor tyrosine-protein kinase</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/MUSK" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MUSK database</a><br /><a href="https://databases.lovd.nl/shared/genes/MUSK" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MUSK homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MUSK" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MUSK</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MUSK[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MUSK</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4649" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MYO9A</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4649" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">15q23</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/B2RTY4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Unconventional myosin-IXa</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MYO9A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MYO9A</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MYO9A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MYO9A</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5339" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PLEC</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5339" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q15149" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Plectin</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/PLEC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PLEC homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PLEC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PLEC</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PLEC[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PLEC</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9581" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PREPL</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9581" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2p21</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q4J6C6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Prolyl endopeptidase-like</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/PREPL" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PREPL database</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PREPL" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PREPL</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PREPL[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PREPL</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5913" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>RAPSN</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5913" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p11<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q13702" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">43 kDa receptor-associated protein of the synapse</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/RAPSN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RAPSN database</a><br /><a href="https://databases.lovd.nl/shared/genes/RAPSN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RAPSN homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=RAPSN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RAPSN</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RAPSN[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RAPSN</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6329" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SCN4A</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6329" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17q23<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P35499" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sodium channel protein type 4 subunit alpha </a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.lovd.nl/SCN4A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sodium channel, voltage-gated, type IV, alpha subunit (SCN4A) @ LOVD</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SCN4A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN4A</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SCN4A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN4A</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/60482" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SLC5A7</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=60482" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q12<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9GZV3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">High affinity choline transporter 1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SLC5A7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC5A7</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SLC5A7[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC5A7</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6576" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SLC25A1</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6576" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q11<wbr style="display:inline-block"></wbr>​.21</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P53007" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Tricarboxylate transport protein, mitochondrial</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SLC25A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC25A1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SLC25A1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC25A1</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6616" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SNAP25</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6616" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">20p12<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P60880" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Synaptosomal-associated protein 25</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SNAP25" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SNAP25</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SNAP25[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SNAP25</a></td></tr><tr><td headers="hd_b_cms.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/127833" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SYT2</i></a></td><td headers="hd_b_cms.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=127833" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q32<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8N9I0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Synaptotagmin-2</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cms.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SYT2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SYT2</a></td><td headers="hd_b_cms.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SYT2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SYT2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cms.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cms.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Congenital Myasthenic Syndromes (<a href="/omim/100690,100710,100720,100725,103320,118490,138292,150325,190315,191350,254210,254300,601296,601462,601592,603033,603034,603967,604270,604875,605809,607905,608761,608930,608931,609557,610285,612866,614198,614750,615120,615320,616040,616227,616228,616304,616313,616314,616321,616322,616323,616324,616325,616326,616330,616720" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1168/table/cms.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cms.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/100690" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">100690</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHOLINERGIC RECEPTOR, NICOTINIC, ALPHA POLYPEPTIDE 1; CHRNA1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/100710" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">100710</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHOLINERGIC RECEPTOR, NICOTINIC, BETA POLYPEPTIDE 1; CHRNB1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/100720" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">100720</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHOLINERGIC RECEPTOR, NICOTINIC, DELTA POLYPEPTIDE; CHRND</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/100725" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">100725</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHOLINERGIC RECEPTOR, NICOTINIC, EPSILON POLYPEPTIDE; CHRNE</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/103320" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">103320</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">AGRIN; AGRN</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/118490" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">118490</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHOLINE ACETYLTRANSFERASE; CHAT</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/138292" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">138292</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 1; GFPT1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/150325" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">150325</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LAMININ, BETA-2; LAMB2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/190315" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">190315</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, CITRATE TRANSPORTER), MEMBER 1; SLC25A1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/191350" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">191350</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINE PHOSPHOTRANSFERASE; DPAGT1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/254210" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">254210</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/254300" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">254300</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 10; CMS10</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601296" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601296</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MUSCLE, SKELETAL, RECEPTOR TYROSINE KINASE; MUSK</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601462" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601462</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601592" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601592</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">RECEPTOR-ASSOCIATED PROTEIN OF THE SYNAPSE, 43-KD; RAPSN</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603033" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603033</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COLLAGENIC TAIL OF ENDPLATE ACETYLCHOLINESTERASE; COLQ</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603034" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603034</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603967" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603967</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, ALPHA SUBUNIT; SCN4A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604270" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604270</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 4; LRP4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604875" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604875</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYOSIN IXA; MYO9A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605809" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605809</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607905" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607905</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ALG2, S. CEREVISIAE, HOMOLOG OF; ALG2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608761" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608761</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SOLUTE CARRIER FAMILY 5 (CHOLINE TRANSPORTER), MEMBER 7; SLC5A7</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608930" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608930</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608931" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608931</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609557" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609557</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PROLYL ENDOPEPTIDASE-LIKE; PREPL</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610285" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610285</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DOWNSTREAM OF TYROSINE KINASE 7; DOK7</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612866" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612866</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ALG14, S. CEREVISIAE, HOMOLOG OF; ALG14</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614198" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614198</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614750" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614750</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 13; CMS13</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615120" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615120</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615320" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615320</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GDP-MANNOSE PYROPHOSPHORYLASE B; GMPPB</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616040" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616040</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616227" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616227</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616228" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616228</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616304" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616304</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616313" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616313</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616314" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616314</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616321" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616321</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616322" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616322</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616323" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616323</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616324" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616324</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616325" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616325</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616326" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616326</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616330" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616330</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616720" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616720</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19</td></tr></tbody></table></div></div><div id="cms.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The understanding of the molecular basis of the different subtypes of CMS has been evolving since 1995. After the identification of pathogenic variants in the subunits of the nicotinic acetylcholine receptor (AChR), other genes encoding postsynaptic, presynaptic, or synaptic proteins were identified as candidate genes for CMS [<a class="bk_pop" href="#cms.REF.engel.2003.339">Engel et al 2003</a>, <a class="bk_pop" href="#cms.REF.hanta_.2004.539">Hanta&#x000ef; et al 2004</a>, <a class="bk_pop" href="#cms.REF.ohno.2004a.117">Ohno &#x00026; Engel 2004a</a>, <a class="bk_pop" href="#cms.REF.beeson.2005.498">Beeson et al 2005</a>, <a class="bk_pop" href="#cms.REF.engel.2005.308">Engel &#x00026; Sine 2005</a>, <a class="bk_pop" href="#cms.REF.m_ller.2007b.1">M&#x000fc;ller et al 2007b</a>]. Currently, several proteins expressed at the neuromuscular junction and involved in neuromuscular transmission have been found to be involved in CMS. CMS subtypes have been classified according to the site of the underlying defect into presynaptic, synaptic, and postsynaptic CMS. This classification is still tentative because it is likely that additional subtypes of CMS will be discovered.</p><p><b>The neuromuscular junction (NMJ).</b> Neuromuscular transmission depends on the calcium-dependent release of acetylcholine (ACh) from the presynaptic nerve terminal and its interaction with AChRs on the postsynaptic membrane. ACh is first synthesized in the motor nerve terminal by the action of the enzyme choline acetyltransferase (ChAT), and is transported into the synaptic vesicles via a specific uptake mechanism. Following depolarization of the motor nerve terminal by the axonal action potential, calcium influx via voltage-gated calcium channels triggers events that lead to vesicle fusion and release of acetylcholine. Binding of ACh to AChR leads to the opening of the AChR ion channel resulting in depolarization of the postsynaptic membrane. If this depolarization exceeds that required to open the voltage-gated sodium channels on the postsynaptic side, an action potential is generated and propagated throughout the muscle fiber, leading to contraction of the muscle. ACh is hydrolyzed by the enzyme acetylcholinesterase (AChE), which is localized at the basal lamina of the NMJ, and the membrane potential of the presynaptic membrane is restored when voltage-gated potassium channels open.</p><p><b>The majority of postsynaptic CMS subtypes</b> involve mutation of the genes <i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, and <i>CHRNE</i> encoding, respectively, the five homologous subunits of the adult AChR: two &#x003b1; subunits, and one each of &#x003b2;, &#x003b4;, and &#x003b5;. Mutation of these genes either increases or decreases the response to acetylcholine. After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to the opening of an ion-conducting channel. Each of the homologous subunits has a large N-terminal extracellular <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, four transmembrane segments (M1-M4) with the M2 domain lining the cation-selective pore. Each AChR has two acetylcholine binding pockets, one at the &#x003b1;/&#x003b5; interface and one at the &#x003b1;/&#x003b4; interface.</p><p>CMS with kinetic abnormalities of the acetylcholine receptor (slow-channel syndromes and fast-channel syndromes) is caused by pathogenic variants in the acetylcholine receptor subunit genes <i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, and <i>CHRNE</i>. Two major kinetic abnormalities of AChR, resulting in slow-channel syndromes and fast-channel syndromes, have emerged. The two kinetic syndromes are physiologic and morphologic opposites and call for different therapeutic modalities.</p><p>The AChR subunits in individuals with CMS have numerous <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or, more frequently, <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pathogenic variants that result in a reduced number of functional AChRs at the postsynaptic membrane. Although these low-expressor or <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> variants have been reported in all the genes encoding subunits of the adult AChR (i.e., <i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, and <i>CHRNE</i>), they are concentrated in <i>CHRNE</i> (encoding the &#x003b5; subunit), especially in its long cytoplasmic M3/M4 linker. Click <a href="/books/NBK1168/bin/cms-AChR_subunit.pdf">here</a> for more information on the AChR subunit genes.</p><div id="cms.CHAT"><h4><i>CHAT</i></h4><p><b>Gene structure.</b> A presynaptic subtype of CMS has been linked to pathogenic variants in <i>CHAT</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding choline O-acetyltransferase (ChAT) [<a class="bk_pop" href="#cms.REF.ohno.2001.2017">Ohno et al 2001</a>]. <i>CHAT</i> comprises 18 exons. For a detailed summary of gene and protein information, see <a href="/books/NBK1168/#cms.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Loss-of-function variants (pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, frameshift, and stop variants) causing <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> CMS have been identified in more than 40 kinships with CMS clinically characterized as CMS-EA (episodic apnea) [<a class="bk_pop" href="#cms.REF.chaouch.2012a.566">Chaouch et al 2012a</a>].</p><div id="cms.T.selected_chat_pathogenic_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>CHAT</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1168/table/cms.T.selected_chat_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cms.T.selected_chat_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cms.T.selected_chat_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cms.T.selected_chat_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cms.T.selected_chat_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cms.T.selected_chat_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.914T&#x0003e;C</td><td headers="hd_h_cms.T.selected_chat_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile305Thr</td><td headers="hd_h_cms.T.selected_chat_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_020549.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020549<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_065574.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_065574<wbr style="display:inline-block"></wbr>​.3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> ChAT catalyzes the reversible synthesis of acetylcholine from acetyl-coenzyme A and choline.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Biochemical studies have established reduced catalytic efficiency and/or reduced expression of mutated gene products.</p></div><div id="cms.CHRNE"><h4><i>CHRNE</i></h4><p><b>Gene structure.</b> The <i>CHRNE</i> reference sequence <a href="/nuccore/NM_000080.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000080.3</a> comprises 12 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1168/#cms.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date, more than 50 &#x003b5; subunit pathogenic variants have been reported [<a class="bk_pop" href="#cms.REF.ohno.2004a.117">Ohno &#x00026; Engel 2004a</a>, <a class="bk_pop" href="#cms.REF.engel.2005.308">Engel &#x00026; Sine 2005</a>].</p><ul><li class="half_rhythm"><div>Most such pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, or frameshift variants resulting in a premature termination of the translational chain.</div></li><li class="half_rhythm"><div>Missense variants alter residues essential for assembly (e.g., glycosylation sites, the cystine loop) or in the signal peptide, also resulting in reduced <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression. Some <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants affecting AChR gene expression also have accompanying kinetic effects.</div></li><li class="half_rhythm"><div>Single-nucleotide variants of a regulatory element (N-box) in the AChR&#x003b5; <a class="def" href="/books/n/gene/glossary/def-item/promoter-region/">promoter region</a> have been shown to result in reduced <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression [<a class="bk_pop" href="#cms.REF.nichols.1999.439">Nichols et al 1999</a>, <a class="bk_pop" href="#cms.REF.ohno.1999.131">Ohno et al 1999</a>, <a class="bk_pop" href="#cms.REF.abicht.2002.1005">Abicht et al 2002</a>].</div></li><li class="half_rhythm"><div>A chromosomal microdeletion of 1,290 bp encompassing parts of <i>CHRNE</i> has been shown to result in CMS [<a class="bk_pop" href="#cms.REF.abicht.2002.1005">Abicht et al 2002</a>].</div></li></ul><p>One particular <a class="def" href="/books/n/gene/glossary/def-item/single-nucleotide-variant/">single-nucleotide variant</a> in the AChR&#x003b5; subunit (c.1327delG) resulting in endplate AChR deficiency has been shown to be common (~50%) in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of Romany and/or southeastern European ethnic origin [<a class="bk_pop" href="#cms.REF.abicht.1999.1564">Abicht et al 1999</a>, <a class="bk_pop" href="#cms.REF.karcagi.2001.231">Karcagi et al 2001</a>, <a class="bk_pop" href="#cms.REF.morar.2004.596">Morar et al 2004</a>].</p><p>Another <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the AChR&#x003b5; subunit (c.1353dupG) is frequent in the Maghreb (especially Algeria and Tunisia), likely because of an ancient <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> [<a class="bk_pop" href="#cms.REF.beeson.2005.498">Beeson et al 2005</a>].</p><div id="cms.T.selected_chrne_pathogenic_variants" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>CHRNE</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1168/table/cms.T.selected_chrne_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cms.T.selected_chrne_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHRNE</i></td><td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.130dupG</td><td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu44GlyfsTer3</td><td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_4" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000080.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000080<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_000071.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000071<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1327delG<br />(&#x003b5;1267delG)</td><td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu443LysfsTer64</td></tr><tr><td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1353dupG<br />(&#x003b5;1293insG)</td><td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn452GlufsTer4</td></tr><tr><td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">(del1290)&#x000a0;<sup>2</sup></td><td headers="hd_h_cms.T.selected_chrne_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Null</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="cms.TF.4.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="cms.TF.4.2"><p class="no_margin">1,290-bp <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> from the promoter to <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 [<a class="bk_pop" href="#cms.REF.abicht.2002.1005">Abicht et al 2002</a>]</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>CHRNE</i> (<a href="/protein/NP_000071.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000071.1</a>) comprises 493 amino acids.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Morphologic studies of endplates show an increased number of endplate regions distributed over an increased span of the muscle fiber. The integrity of the junctional folds is preserved, but AChR expression on the folds is patchy and faint. The fetal type &#x003b3; subunit may partially compensate for absence of the &#x003b5; subunit, thereby producing a less severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p></div><div id="cms.COLQ"><h4><i>COLQ</i></h4><p><b>Gene structure.</b> A synaptic subtype of CMS has been linked to pathogenic variants in <i>COLQ</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding the collagenic tail ColQ. <i>COLQ</i> comprises 17 exons (and 2 alternate exons: 1A and 11A).</p><p><b>Pathogenic variants.</b> All individuals with endplate (EP) AChE deficiency described to date have pathogenic variants in <i>COLQ</i>. To date, pathogenic variants (<a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, frameshift, stop, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants) causing <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> CMS have been identified in more than 100 CMS kinships [<a class="bk_pop" href="#cms.REF.chaouch.2012a.566">Chaouch et al 2012a</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The endplate species of AChE is a heteromeric asymmetric enzyme composed of one, two, or three homotetramers of globular catalytic subunits (AChE<sub>T</sub>) attached to a triple-stranded collagenic tail (ColQ) anchoring the enzyme to the synaptic basal lamina. ColQ has an N-terminal proline-rich region attachment <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (PRAD), a collagenic central domain, and a C-terminal region enriched in charged residues and cysteines. Each ColQ strand can bind an AChE<sub>T</sub> tetramer to its PRAD, giving rise to A<sub>4</sub>, A<sub>8</sub>, and A<sub>12</sub> species of asymmetric AChE. Two groups of charged residues in the collagen domain (heparan sulfate proteoglycan binding domains [HSPBD]) plus other residues in the C-terminal region assure that the asymmetric enzyme is inserted into the synaptic basal lamina. The C-terminal region is also required for initiating the triple helical assembly of ColQ that proceeds from a C- to an N-terminal direction in a zipper-like manner.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>COLQ</i>-associated synaptic subtype of CMS is caused by the absence of acetylcholinesterase (AChE) from the synaptic cleft as a result of pathogenic variants in the triple-stranded collagenic tail (ColQ) anchoring the enzyme to the synaptic basal lamina [<a class="bk_pop" href="#cms.REF.donger.1998.967">Donger et al 1998</a>, <a class="bk_pop" href="#cms.REF.ohno.1998.9654">Ohno et al 1998</a>, <a class="bk_pop" href="#cms.REF.ohno.2000.162">Ohno et al 2000</a>].</p><p>Biochemical studies have established three major functional consequences resulting from pathogenic variants:</p><ul><li class="half_rhythm"><div>Pathogenic variants in the PRAD-<a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> prevent attachment of AChE<sub>T</sub> to ColQ;</div></li><li class="half_rhythm"><div>Pathogenic variants in the collagen-<a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> produce a short, single-stranded ColQ that binds a single AChE<sub>T</sub> tetramer and is insertion incompetent;</div></li><li class="half_rhythm"><div>Pathogenic variants in the C-terminus hinder the triple helical assembly of the collagen <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, or produce an asymmetric species of AChE that is insertion incompetent, or both.</div></li></ul><p>Neuromuscular transmission in absence of AChE is compromised by a desensitization and depolarization block of AChR at physiologic rates of stimulation, an endplate myopathy caused by cholinergic overactivity with a likely compensatory smallness of the nerve terminals and their encasement by Schwann cells. Endplate potentials and currents are prolonged in the absence of AChE, eliciting repetitive compound muscle action potentials.</p></div><div id="cms.DOK7"><h4><i>DOK7</i></h4><p><b>Gene structure.</b>
<i>DOK7</i>, encoding the postsynaptic protein Dok-7, comprises seven exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1168/#cms.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b>
<i>DOK7</i> pathogenic variants were recently identified in individuals with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myasthenic syndromes affecting primarily the proximal limb muscles ("limb-girdle myasthenia") [<a class="bk_pop" href="#cms.REF.beeson.2006.1975">Beeson et al 2006</a>, <a class="bk_pop" href="#cms.REF.m_ller.2007a.1497">M&#x000fc;ller et al 2007a</a>, <a class="bk_pop" href="#cms.REF.palace.2007.1507">Palace et al 2007</a>]. Since then, a large number of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> pathogenic variants have been reported in more than 150 kinships [<a class="bk_pop" href="#cms.REF.chaouch.2012a.566">Chaouch et al 2012a</a>]. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have the C-terminal frameshift c.1124_1127dupTGCC on at least one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</p><div id="cms.T.selected_dok7_pathogenic_variants" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Selected <i>DOK7</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1168/table/cms.T.selected_dok7_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cms.T.selected_dok7_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cms.T.selected_dok7_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cms.T.selected_dok7_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cms.T.selected_dok7_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cms.T.selected_dok7_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1124_1127dupTGCC</td><td headers="hd_h_cms.T.selected_dok7_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala378SerfsTer30</td><td headers="hd_h_cms.T.selected_dok7_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_173660.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_173660<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_775931.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_775931<wbr style="display:inline-block"></wbr>​.3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Dok ("downstream of kinase") -7 is a 43-kd MuSK-interacting postsynaptic protein [<a class="bk_pop" href="#cms.REF.okada.2006.1802">Okada et al 2006</a>] that is essential for synaptogenesis. Previously known Dok-family proteins (Dok-1 to Dok-6) play a role in signaling downstream of receptor and non-receptor phosphotyrosine kinases. Like other Dok proteins, Dok-7 has a pleckstrin-homology (PH) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and a phosphotyrosine-binding (PTB) domain in the N-terminal moiety and multiple tyrosine residues in the C-terminal region.</p><p><a class="bk_pop" href="#cms.REF.okada.2006.1802">Okada et al [2006]</a> demonstrated that Dok-7 overexpression can induce the aneural activation of MuSK and subsequent clustering of AChR in cultured myotubes. Unique among adaptor proteins recruited to receptor tyrosine kinases, Dok7 is not only a substrate of MuSK but also an activator of MuSK's kinase activity.</p><p>The crystal structure of the Dok7 PH-PTB domains in complex with a phosphopeptide representing the Dok7-binding site on MuSK revealed a dimeric arrangement of Dok7 PH-PTB that facilitates transautophosphorylation of the kinase activation loop [<a class="bk_pop" href="#cms.REF.bergamin.2010.100">Bergamin et al 2010</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Analysis of AChR clusters induced by Dok-7 harboring the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.1124_1127dupTGCC showed a significant reduction in the number of branched-type AChR plaques compared to wild type Dok-7 in fully differentiated transfected C2C12 myotubes [<a class="bk_pop" href="#cms.REF.beeson.2006.1975">Beeson et al 2006</a>]. By contrast, the ability of the c.1124_1127dupTGCC mutant to bind and induce MuSK phosphorylation was not impaired in non-differentiated myoblasts and in heterologous cells, suggesting that the C-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> could play a key role in the maturation of the synaptic structure. Other pathogenic variants in the C-terminal domain of Dok-7 may have similar effects in myotubes.</p></div><div id="cms.GFPT1"><h4><i>GFPT1</i></h4><p><b>Gene structure.</b>
<i>GFPT1</i> comprises 19 exons, plus one additional alternative <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 8A, which is incorporated only into a longer isoform <i>GFPT1L</i>, resulting in the <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> of 18 additional amino acids. <i>GFPT1L</i> is mainly expressed in skeletal muscle and heart and is the predominant <i>GFPT1</i> species in these tissues [<a class="bk_pop" href="#cms.REF.niimi.2001.566">Niimi et al 2001</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1168/#cms.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b>
<i>GFPT1</i> pathogenic variants have been identified in more than 20 individuals with a subtype of CMS referred to as <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myasthenic syndrome with tubular aggregates (CMS-TA) [<a class="bk_pop" href="#cms.REF.senderek.2011.162">Senderek et al 2011</a>, <a class="bk_pop" href="#cms.REF.guergueltcheva.2012.838">Guergueltcheva et al 2012</a>]. Nineteen different <i>GFPT1</i> pathogenic variants comprising 13 <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants, four frameshifts, one <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant, and one variant in the 3'-UTR were identified. No individual with CMS with two <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> variants in the constitutive exons resulting in a complete loss of GFPT1 expression has been identified.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>GFPT1</i> encodes an 80-kd enzyme that is part of the hexosamine biosynthesis pathway. GFPT1 catalyzes the transfer of an amino group from glutamine onto fructose-6-phosphate, yielding glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 and glutamate. This transamidase reaction has been identified as the first and rate-limiting step of the hexosamine biosynthesis pathway. Products of this biochemical pathway are the sugar building blocks for the glycosylation of proteins and lipids in all cells.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>GFPT1</i> lead to reduced protein levels in muscle; some <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants also slightly reduce the enzymatic activity [<a class="bk_pop" href="#cms.REF.senderek.2011.162">Senderek et al 2011</a>]. The precise mechanism by which GFPT1 deficiency induces a dysfunction of the neuromuscular junction is not yet understood.</p></div><div id="cms.RAPSN"><h4><i>RAPSN</i></h4><p><b>Gene structure.</b>
<i>RAPSN</i>, encoding the postsynaptic protein rapsyn (43-kd receptor-associated protein of the synapse), comprises eight exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1168/#cms.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Nearly 200 pathogenic variants in <i>RAPSN</i> have been identified to date in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> (<a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, frameshift, stop, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants) and the <a class="def" href="/books/n/gene/glossary/def-item/promoter-region/">promoter region</a> [<a class="bk_pop" href="#cms.REF.ohno.2004a.117">Ohno &#x00026; Engel 2004a</a>, <a class="bk_pop" href="#cms.REF.engel.2005.308">Engel &#x00026; Sine 2005</a>, <a class="bk_pop" href="#cms.REF.m_ller.2007b.1">M&#x000fc;ller et al 2007b</a>, <a class="bk_pop" href="#cms.REF.milone.2009.228">Milone et al 2009</a>, <a class="bk_pop" href="#cms.REF.chaouch.2012a.566">Chaouch et al 2012a</a>].</p><ul><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant c.264C&#x0003e;A (p.Asn88Lys) has been identified in many individuals who have pathogenic variants in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> in at least one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. There is evidence for an ancient Indo-European founder [<a class="bk_pop" href="#cms.REF.richard.2003.e81">Richard et al 2003</a>, <a class="bk_pop" href="#cms.REF.m_ller.2004a.e104">M&#x000fc;ller et al 2004a</a>]; however, not all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with c.264C&#x0003e;A have the same haplotype [<a class="bk_pop" href="#cms.REF.richard.2003.e81">Richard et al 2003</a>, <a class="bk_pop" href="#cms.REF.ohno.2004b.e8">Ohno &#x00026; Engel 2004b</a>].</div></li><li class="half_rhythm"><div>Other pathogenic variants in the translated region are dispersed over different domains of the protein.</div></li><li class="half_rhythm"><div>One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual was found to be a compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> with the c.264C&#x0003e;A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and a large (~4.5-kb) <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> disrupting the other <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#cms.REF.m_ller.2004b.744">M&#x000fc;ller et al 2004b</a>].</div></li><li class="half_rhythm"><div>Heteroallelic multiexon deletions may be common and present in up to 15% of cases [<a class="bk_pop" href="#cms.REF.gaudon.2010.795">Gaudon et al 2010</a>].</div></li><li class="half_rhythm"><div>Pathogenic variants in E-box regions of the promoter have been identified (<a class="figpopup" href="/books/NBK1168/table/cms.T.selected_rapsn_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figcmsTselectedrapsnpathogenicvariants" rid-ob="figobcmsTselectedrapsnpathogenicvariants">Table 6</a>).</div></li></ul><div id="cms.T.selected_rapsn_pathogenic_variants" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Selected <i>RAPSN</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1168/table/cms.T.selected_rapsn_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cms.T.selected_rapsn_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias)&#x000a0;<sup>1</sup></th><th id="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.-210A&#x0003e;G&#x000a0;<sup>2,&#x000a0;3</sup><br />(-38A&#x0003e;G)&#x000a0;<sup>4</sup></td><td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_005055.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005055<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_005046.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005046<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.-199C&#x0003e;G&#x000a0;<sup>2,&#x000a0;5</sup><br />(-27C&#x0003e;G)&#x000a0;<sup>4</sup></td><td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr><tr><td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.264C&#x0003e;A</td><td headers="hd_h_cms.T.selected_rapsn_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn88Lys</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt></dt><dd><div><p class="no_margin">NA = not applicable</p></div></dd><dt>1. </dt><dd><div id="cms.TF.6.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="cms.TF.6.2"><p class="no_margin">Promoter variants. Number of nucleotides 5' of the ATG translation initiation codon</p></div></dd><dt>3. </dt><dd><div id="cms.TF.6.3"><p class="no_margin">An E-box <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, c.-210A&#x0003e;G observed in the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> state, arose from a common founder in Near-Eastern Jews with marked jaw and other facial malformations [<a class="bk_pop" href="#cms.REF.ohno.2003.739">Ohno et al 2003</a>].</p></div></dd><dt>4. </dt><dd><div id="cms.TF.6.4"><p class="no_margin">Alias designations are number of nucleotides 5' of the transcription start site.</p></div></dd><dt>5. </dt><dd><div id="cms.TF.6.5"><p class="no_margin">One E-box <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, c.-199C&#x0003e;G, was <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> with the c.264C&#x0003e;A pathogenic variant [<a class="bk_pop" href="#cms.REF.ohno.2003.739">Ohno et al 2003</a>].</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Rapsyn, a 43-kd postsynaptic protein, plays an essential role in the clustering of AChR at the endplate. It self-associates, aggregates AChRs, and links them to the subsynaptic cytoskeleton.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> EP studies in each case have shown decreased staining for rapsyn and AChR, as well as impaired postsynaptic development. Expression studies of mutated constructs indicate that many pathogenic variants diminished co-clustering of AChR with rapsyn. For some <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, however, different pathogenic mechanisms that inhibited self-association of rapsyn or reduced the stability of the rapsyn protein have been discovered [<a class="bk_pop" href="#cms.REF.cossins.2006.2773">Cossins et al 2006</a>].</p></div><div id="cms.Less_Common_Genetic_Causes_of_CMS"><h4>Less Common Genetic Causes of CMS</h4><p>Click <a href="/books/NBK1168/bin/cms-less_common_genes.pdf">here</a> (pdf) for more detailed information on select genes from <a class="figpopup" href="/books/NBK1168/table/cms.T.molecular_genetics_congenital_myas/?report=objectonly" target="object" rid-figpopup="figcmsTmoleculargeneticscongenitalmyas" rid-ob="figobcmsTmoleculargeneticscongenitalmyas">Table 1b</a>.</p></div></div></div><div id="cms.References"><h2 id="_cms_References_">References</h2><div id="cms.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cms.REF.abicht.2012.1474">Abicht A, Dusl M, Gallenm&#x000fc;ller C, Guergueltcheva V, Schara U, Della Marina A, Wibbeler E, Almaras S, Mihaylova V, von der Hagen M, Huebner A, Chaouch A, M&#x000fc;ller JS, Lochm&#x000fc;ller H. Congenital myasthenic syndromes: achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: a study of 680 patients. <span><span class="ref-journal">Hum Mutat. </span>2012;<span class="ref-vol">33</span>:1474–84.</span> [<a href="/pubmed/22678886" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22678886</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.abicht.1999.1564">Abicht A, Stucka R, Karcagi V, Herczegfalvi A, Horvath R, Mortier W, Schara U, Ramaekers V, Jost W, Brunner J, Janssen G, Seidel U, Schlotter B, M&#x000fc;ller-Felber W, Pongratz D, Rudel R, Lochmuller H. A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin. <span><span class="ref-journal">Neurology. </span>1999;<span class="ref-vol">53</span>:1564–9.</span> [<a href="/pubmed/10534268" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10534268</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.abicht.2002.1005">Abicht A, Stucka R, Schmidt C, Briguet A, Hopfner S, Song IH, Pongratz D, M&#x000fc;ller-Felber W, Ruegg MA, Lochmuller H. A newly identified chromosomal microdeletion and an N-box mutation of the AChR epsilon gene cause a congenital myasthenic syndrome. <span><span class="ref-journal">Brain. </span>2002;<span class="ref-vol">125</span>:1005–13.</span> [<a href="/pubmed/11960891" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11960891</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.basiri.2013.469">Basiri K, Belaya K, Liu WW, Maxwell S, Sedghi M, Beeson D. Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1. <span><span class="ref-journal">Neuromuscul Disord. </span>2013;<span class="ref-vol">23</span>:469–72.</span> [<a href="/pmc/articles/PMC3746154/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3746154</span></a>] [<a href="/pubmed/23591138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23591138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.beeson.2005.498">Beeson D, Hantai D, Lochmuller H, Engel AG. 126th International Workshop: congenital myasthenic syndromes, 24-26 September 2004, Naarden, the Netherlands. <span><span class="ref-journal">Neuromuscul Disord. </span>2005;<span class="ref-vol">15</span>:498–512.</span> [<a href="/pubmed/15951177" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15951177</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.beeson.2006.1975">Beeson D, Higuchi O, Palace J, Cossins J, Spearman H, Maxwell S, Newsom-Davis J, Burke G, Fawcett P, Motomura M, M&#x000fc;ller JS, Lochm&#x000fc;ller H, Slater C, Vincent A, Yamanashi Y. Dok-7 mutations underlie a neuromuscular junction synaptopathy. <span><span class="ref-journal">Science. </span>2006;<span class="ref-vol">313</span>:1975–8.</span> [<a href="/pubmed/16917026" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16917026</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.belaya.2012a.29">Belaya K, Finlayson S, Cossins J, Liu WW, Maxwell S, Palace J, Beeson D. Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome. <span><span class="ref-journal">Ann N Y Acad Sci. </span>2012a;<span class="ref-vol">1275</span>:29–35.</span> [<a href="/pmc/articles/PMC6044425/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6044425</span></a>] [<a href="/pubmed/23278575" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23278575</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.belaya.2012b.193">Belaya K, Finlayson S, Slater CR, Cossins J, Liu WW, Maxwell S, McGowan SJ, Maslau S, Twigg SR, Walls TJ. Pascual Pascual SI, Palace J, Beeson D. Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates. <span><span class="ref-journal">Am J Hum Genet. </span>2012b;<span class="ref-vol">91</span>:193–201.</span> [<a href="/pmc/articles/PMC3397259/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3397259</span></a>] [<a href="/pubmed/22742743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22742743</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.belaya.2015.2493">Belaya K, Rodr&#x000ed;guez Cruz PM, Liu WW, Maxwell S, McGowan S, Farrugia ME, Petty R, Walls TJ, Sedghi M, Basiri K, Yue WW, Sarkozy A, Bertoli M, Pitt M, Kennett R, Schaefer A, Bushby K, Parton M, Lochm&#x000fc;ller H, Palace J, Muntoni F, Beeson D. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:2493–504.</span> [<a href="/pmc/articles/PMC4547052/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4547052</span></a>] [<a href="/pubmed/26133662" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26133662</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.ben_ammar.2010.754">Ben Ammar A, Petit F, Alexandri N, Gaudon K, Bauch&#x000e9; S, Rouche A, Gras D, Fournier E, Koenig J, Stojkovic T, Lacour A, Petiot P, Zagnoli F, Viollet L, Pellegrini N, Orlikowski D, Lazaro L, Ferrer X, Stoltenburg G, Paturneau-Jouas M, Hentati F, Fardeau M, Sternberg D, Hanta&#x000ef; D, Richard P, Eymard B. Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7. <span><span class="ref-journal">J Neurol. </span>2010;<span class="ref-vol">257</span>:754–66.</span> [<a href="/pubmed/20012313" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20012313</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.bergamin.2010.100">Bergamin E, Hallock PT, Burden SJ, Hubbard SR. The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization. <span><span class="ref-journal">Mol Cell. </span>2010;<span class="ref-vol">39</span>:100–9.</span> [<a href="/pmc/articles/PMC2917201/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2917201</span></a>] [<a href="/pubmed/20603078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20603078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.bestuecardiel.2005.144">Bestue-Cardiel M, S&#x000e1;enz de Cabez&#x000f3;n-Alvarez A, Capablo-Liesa JL, L&#x000f3;pez-Pis&#x000f3;n J, Pe&#x000f1;a-Segura JL, Martin-Martinez J, Engel AG. Congenital endplate acetylcholinesterase deficiency responsive to ephedrine. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">65</span>:144–6.</span> [<a href="/pubmed/16009904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16009904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.brownlow.2001.125">Brownlow S, Webster R, Croxen R, Brydson M, Neville B, Lin JP, Vincent A, Newsom-Davis J, Beeson D. Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita. <span><span class="ref-journal">J Clin Invest. </span>2001;<span class="ref-vol">108</span>:125–30.</span> [<a href="/pmc/articles/PMC209343/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC209343</span></a>] [<a href="/pubmed/11435464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11435464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.burke.2013.170">Burke G, Hiscock A, Klein A, Niks EH, Main M, Manzur AY, Ng J, de Vile C, Muntoni F, Beeson D, Robb S. Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations. <span><span class="ref-journal">Neuromuscul Disord. </span>2013;<span class="ref-vol">23</span>:170–5.</span> [<a href="/pubmed/23219351" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23219351</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.burke.2003.826">Burke G, Cossins J, Maxwell S, Owens G, Vincent A, Robb S, Nicolle M, Hilton-Jones D, Newsom-Davis J, Palace J, Beeson D. Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">61</span>:826–8.</span> [<a href="/pubmed/14504330" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14504330</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.burke.2004.356">Burke G, Cossins J, Maxwell S, Robb S, Nicolle M, Vincent A, Newsom-Davis J, Palace J, Beeson D. Distinct phenotypes of congenital acetylcholine receptor deficiency. <span><span class="ref-journal">Neuromuscul Disord. </span>2004;<span class="ref-vol">14</span>:356–64.</span> [<a href="/pubmed/15145336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15145336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.byring.2002.548">Byring RF, Pihko H, Tsujino A, Shen XM, Gustafsson B, Hackman P, Ohno K, Engel AG, Udd B. Congenital myasthenic syndrome associated with episodic apnea and sudden infant death. <span><span class="ref-journal">Neuromuscul Disord. </span>2002;<span class="ref-vol">12</span>:548–53.</span> [<a href="/pubmed/12117478" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12117478</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.chaouch.2012a.566">Chaouch A, Beeson D, Hanta&#x000ef; D, Lochm&#x000fc;ller H. 186th ENMC International Workshop: Congenital myasthenic syndromes 24-26 June 2011, Naarden, The Netherlands. <span><span class="ref-journal">Neuromuscul Disord. </span>2012a;<span class="ref-vol">22</span>:566–76.</span> [<a href="/pubmed/22230109" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22230109</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.chaouch.2012b.474">Chaouch A, M&#x000fc;ller JS, Guergueltcheva V, Dusl M, Schara U, Rakocevi&#x00107;-Stojanovi&#x00107; V, Lindberg C, Scola RH, Werneck LC, Colomer J, Nascimento A, Vilchez JJ, Muelas N, Argov Z, Abicht A, Lochm&#x000fc;ller H. A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome. <span><span class="ref-journal">J Neurol. </span>2012b;<span class="ref-vol">259</span>:474–81.</span> [<a href="/pubmed/21822932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21822932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.chaouch.2014.75">Chaouch A, Porcelli V, Cox D, Edvardson S, Scarcia P, De Grassi A, Pierri CL, Cossins J, Laval SH, Griffin H, M&#x000fc;ller JS, Evangelista T, T&#x000f6;pf A, Abicht A, Huebner A, von der Hagen M, Bushby K, Straub V, Horvath R, Elpeleg O, Palace J, Senderek J, Beeson D, Palmieri L, Lochm&#x000fc;ller H. Mutations in the mitochondrial citrate carrier SLC25A1 are associated with impaired neuromuscular transmission. <span><span class="ref-journal">J Neuromuscul Dis. </span>2014;<span class="ref-vol">1</span>:75–90.</span> [<a href="/pmc/articles/PMC4746751/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4746751</span></a>] [<a href="/pubmed/26870663" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26870663</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.chevessier.2004.3229">Chevessier F, Faraut B, Ravel-Chapuis A, Richard P, Gaudon K, Bauche S, Prioleau C, Herbst R, Goillot E, Ioos C, Azulay JP, Attarian S, Leroy JP, Fournier E, Legay C, Schaeffer L, Koenig J, Fardeau M, Eymard B, Pouget J, Hantai D. MUSK, a new target for mutations causing congenital myasthenic syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2004;<span class="ref-vol">13</span>:3229–40.</span> [<a href="/pubmed/15496425" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15496425</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.colomer.2006.329">Colomer J, M&#x000fc;ller JS, Vernet A, Nascimento A, Pons M, Gonzalez V, Abicht A, Lochm&#x000fc;ller H. Long-term improvement of slow-channel congenital myasthenic syndrome with fluoxetine. <span><span class="ref-journal">Neuromuscul Disord. </span>2006;<span class="ref-vol">16</span>:329–33.</span> [<a href="/pubmed/16621558" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16621558</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.cossins.2013.944">Cossins J, Belaya K, Hicks D, Salih MA, Finlayson S, Carboni N, Liu WW, Maxwell S, Zoltowska K, Farsani GT, Laval S, Seidhamed MZ, Donnelly P, Bentley D, McGowan SJ, M&#x000fc;ller J, Palace J, Lochm&#x000fc;ller H, Beeson D, et al.  Congenital myasthenic syndromes due to mutations in ALG2 and ALG14. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:944–56.</span> [<a href="/pmc/articles/PMC3580273/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3580273</span></a>] [<a href="/pubmed/23404334" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23404334</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.cossins.2006.2773">Cossins J, Burke G, Maxwell S, Spearman H, Man S, Kuks J, Vincent A, Palace J, Fuhrer C, Beeson D. Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:2773–83.</span> [<a href="/pubmed/16945936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16945936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.croxen.2002a.162">Croxen R, Hatton C, Shelley C, Brydson M, Chauplannaz G, Oosterhuis H, Vincent A, Newsom-Davis J, Colquhoun D, Beeson D. Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes. <span><span class="ref-journal">Neurology. </span>2002a;<span class="ref-vol">59</span>:162–8.</span> [<a href="/pubmed/12141316" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12141316</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.croxen.2009.294">Croxen R, Hatton C, Shelley C, Brydson M, Chauplannaz G, Oosterhuis H, Vincent A, Newsom-Davis J, Colquhoun D, Beeson D. Voluntary partial retraction of: Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">72</span>:294.</span> [<a href="/pubmed/19153382" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19153382</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.croxen.1997.767">Croxen R, Newland C, Beeson D, Oosterhuis H, Chauplannaz G, Vincent A, Newsom-Davis J. Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:767–74.</span> [<a href="/pubmed/9158151" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9158151</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.croxen.2002b.1563">Croxen R, Vincent A, Newsom-Davis J, Beeson D. Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations. <span><span class="ref-journal">Neurology. </span>2002b;<span class="ref-vol">58</span>:1563–5.</span> [<a href="/pubmed/12034803" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12034803</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.deymeer.1999.129">Deymeer F, Serdaroglu P, Ozdemir C. Familial infantile myasthenia: confusion in terminology. <span><span class="ref-journal">Neuromuscul Disord. </span>1999;<span class="ref-vol">9</span>:129–30.</span> [<a href="/pubmed/10382904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10382904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.donger.1998.967">Donger C, Krejci E, Serradell AP, Eymard B, Bon S, Nicole S, Chateau D, Gary F, Fardeau M, Massoulie J, Guicheney P. Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic). <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:967–75.</span> [<a href="/pmc/articles/PMC1377491/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377491</span></a>] [<a href="/pubmed/9758617" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9758617</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.engel.2007.252">Engel AG. The therapy of congenital myasthenic syndromes. <span><span class="ref-journal">Neurotherapeutics. </span>2007;<span class="ref-vol">4</span>:252–7.</span> [<a href="/pmc/articles/PMC1978489/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1978489</span></a>] [<a href="/pubmed/17395135" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17395135</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.engel.2003.339">Engel AG, Ohno K, Sine SM. Sleuthing molecular targets for neurological diseases at the neuromuscular junction. <span><span class="ref-journal">Nat Rev Neurosci. </span>2003;<span class="ref-vol">4</span>:339–52.</span> [<a href="/pubmed/12728262" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12728262</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.engel.2015.461">Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. <span><span class="ref-journal">Lancet Neurol. </span>2015;<span class="ref-vol">14</span>:461.</span> [<a href="/pubmed/25895926" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25895926</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.engel.2005.308">Engel AG, Sine SM. Current understanding of congenital myasthenic syndromes. <span><span class="ref-journal">Curr Opin Pharmacol. </span>2005;<span class="ref-vol">5</span>:308–21.</span> [<a href="/pubmed/15907919" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15907919</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.fattahi.2015.60">Fattahi Z, Kahrizi K, Nafissi S, Fadaee M, Abedini SS, Kariminejad A, Akbari MR, Najmabadi H. Report of a patient with limb-girdle muscular dystrophy, ptosis and ophthalmoparesis caused by plectinopathy. <span><span class="ref-journal">Arch Iran Med. </span>2015;<span class="ref-vol">18</span>:60–4.</span> [<a href="/pubmed/25556389" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25556389</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.finlayson.2013.80">Finlayson S, Beeson D, Palace J. Congenital myasthenic syndromes: an update. <span><span class="ref-journal">Pract Neurol. </span>2013;<span class="ref-vol">13</span>:80–91.</span> [<a href="/pubmed/23468559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23468559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.forrest.2010.709">Forrest K, Mellerio JE, Robb S, Dopping-Hepenstal PJ, McGrath JA, Liu L, Buk SJ, Al-Sarraj S, Wraige E, Jungbluth H. Congenital muscular dystrophy, myasthenic symptoms and epidermolysis bullosa simplex (EBS) associated with mutations in the PLEC1 gene encoding plectin. <span><span class="ref-journal">Neuromuscul Disord. </span>2010;<span class="ref-vol">20</span>:709–11.</span> [<a href="/pubmed/20624679" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20624679</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.ganetzky.2015.2411">Ganetzky R, Izumi K, Edmondson A, Muraresku CC, Zackai E, Deardorff M, Ganesh J. Fetal akinesia deformation sequence due to a congenital disorder of glycosylation. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:2411–7.</span> [<a href="/pubmed/26033833" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26033833</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.gaudon.2010.795">Gaudon K, P&#x000e9;nisson-Besnier I, Chabrol B, Bouhour F, Demay L, Ben Ammar A, Bauch&#x000e9; S, Vial C, Nicolas G, Eymard B, Hanta&#x000ef; D, Richard P. Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencing. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:795–6.</span> [<a href="/pubmed/20930056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20930056</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.guergueltcheva.2012.838">Guergueltcheva V, M&#x000fc;ller JS, Dusl M, Senderek J, Oldfors A, Lindbergh C, Maxwell S, Colomer J, Mallebrera CJ, Nascimento A, Vilchez JJ, Muelas N, Kirschner J, Nafissi S, Kariminejad A, Nilipour Y, Bozorgmehr B, Najmabadi H, Rodolico C, Sieb JP, Schlotter B, Schoser B, Herrmann R, Voit T, Steinlein OK, Najafi A, Urtizberea A, Soler DM, Muntoni F, Hanna MG, Chaouch A, Straub V, Bushby K, Palace J, Beeson D, Abicht A, Lochm&#x000fc;ller H. Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations. <span><span class="ref-journal">J Neurol. </span>2012;<span class="ref-vol">259</span>:838–50.</span> [<a href="/pubmed/21975507" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21975507</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.habbout.2016.161">Habbout K, Poulin H, Rivier F, Giuliano S, Sternberg D, Fontaine B, Eymard B, Morales RJ, Echenne B, King L, Hanna MG, M&#x000e4;nnikk&#x000f6; R, Chahine M, Nicole S, Bendahhou S. A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis. <span><span class="ref-journal">Neurology. </span>2016;<span class="ref-vol">86</span>:161–9.</span> [<a href="/pmc/articles/PMC4731685/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731685</span></a>] [<a href="/pubmed/26659129" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26659129</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.hanta_.2013.561">Hanta&#x000ef; D, Nicole S, Eymard B. Congenital myasthenic syndromes: an update. <span><span class="ref-journal">Curr Opin Neurol. </span>2013;<span class="ref-vol">26</span>:561–8.</span> [<a href="/pubmed/23995276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23995276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.hanta_.2004.539">Hanta&#x000ef; D, Richard P, Koenig J, Eymard B. Congenital myasthenic syndromes. <span><span class="ref-journal">Curr Opin Neurol. </span>2004;<span class="ref-vol">17</span>:539–51.</span> [<a href="/pubmed/15367858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15367858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.harper.1998.480">Harper CM, Engel AG. Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome. <span><span class="ref-journal">Ann Neurol. </span>1998;<span class="ref-vol">43</span>:480–4.</span> [<a href="/pubmed/9546329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9546329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.harper.2003.1710">Harper CM, Fukodome T, Engel AG. Treatment of slow-channel congenital myasthenic syndrome with fluoxetine. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">60</span>:1710–3.</span> [<a href="/pubmed/12771277" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12771277</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.herrmann.2014.332">Herrmann DN, Horvath R, Sowden JE, Gonzalez M, Sanchez-Mejias A, Guan Z, Whittaker RG, Almodovar JL, Lane M, Bansagi B, Pyle A, Boczonadi V, Lochm&#x000fc;ller H, Griffin H, Chinnery PF, Lloyd TE, Littleton JT, Zuchner S. Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy. <span><span class="ref-journal">Am J Hum Genet. </span>2014;<span class="ref-vol">95</span>:332–9.</span> [<a href="/pmc/articles/PMC4157148/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4157148</span></a>] [<a href="/pubmed/25192047" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25192047</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.hoch.2001.365">Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. <span><span class="ref-journal">Nat Med. </span>2001;<span class="ref-vol">7</span>:365–8.</span> [<a href="/pubmed/11231638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11231638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.huz_.2009.155">Huz&#x000e9; C, Bauch&#x000e9; S, Richard P, Chevessier F, Goillot E, Gaudon K, Ben Ammar A, Chaboud A, Grosjean I, Lecuyer HA, Bernard V, Rouche A, Alexandri N, Kuntzer T, Fardeau M, Fournier E, Brancaccio A, R&#x000fc;egg MA, Koenig J, Eymard B, Schaeffer L, Hanta&#x000ef; D. Identification of an agrin mutation that causes congenital myasthenia and affects synapse function. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">85</span>:155–67.</span> [<a href="/pmc/articles/PMC2725239/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2725239</span></a>] [<a href="/pubmed/19631309" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19631309</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.jurkatrott.2010.239">Jurkat-Rott K, Holzherr B, Fauler M, Lehmann-Horn F. Sodium channelopathies of skeletal muscle result from gain or loss of function. <span><span class="ref-journal">Pflugers Arch. </span>2010;<span class="ref-vol">460</span>:239–48.</span> [<a href="/pmc/articles/PMC2883924/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2883924</span></a>] [<a href="/pubmed/20237798" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20237798</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.karakaya.2014">Karakaya M, Ceyhan-Birsoy O, Beggs AH, Topaloglu H. A novel missense mutation in the AGRN gene causing congenital myasthenic syndrome mimicking neck myopathy. Berlin, Germany: 19th International Congress of the World-Muscle-Society. 2014.</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.karcagi.2001.231">Karcagi V, Tournev I, Schmidt C, Herczegfalvi A, Guergueltcheva V, Litvinenko I, Song IH, Abicht A, Lochmuller H. Congenital myasthenic syndrome in southeastern European Roma (Gypsies). <span><span class="ref-journal">Acta Myologica. </span>2001;<span class="ref-vol">20</span>:231–8.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.kinali.2008.6">Kinali M, Beeson D, Pitt MC, Jungbluth H, Simonds AK, Aloysius A, Cockerill H, Davis T, Palace J, Manzur AY, Jimenez-Mallebrera C, Sewry C, Muntoni F, Robb SA. Congenital myasthenic syndromes in childhood: diagnostic and management challenges. <span><span class="ref-journal">J Neuroimmunol. </span>2008;<span class="ref-vol">201-202</span>:6–12.</span> [<a href="/pubmed/18707767" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18707767</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.lashley.2010.1517">Lashley D, Palace J, Jayawant S, Robb S, Beeson D. Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">74</span>:1517–23.</span> [<a href="/pmc/articles/PMC2875925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2875925</span></a>] [<a href="/pubmed/20458068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20458068</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.liewluck.2011.789">Liewluck T, Selcen D, Engel AG. Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia. <span><span class="ref-journal">Muscle Nerve. </span>2011;<span class="ref-vol">44</span>:789–94.</span> [<a href="/pmc/articles/PMC3196786/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3196786</span></a>] [<a href="/pubmed/21952943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21952943</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.logan.2015.878">Logan CV, Cossins J, Rodr&#x000ed;guez Cruz PM, Parry DA, Maxwell S, Mart&#x000ed;nez-Mart&#x000ed;nez P, Riepsaame J, Abdelhamed ZA, Lake AV, Moran M, Robb S, Chow G, Sewry C, Hopkins PM, Sheridan E, Jayawant S, Palace J, Johnson CA, Beeson D. Congenital myasthenic syndrome type 19 is caused by mutations in COL13A1, encoding the atypical non-fibrillar collagen type XIII &#x003b1;1 chain. <span><span class="ref-journal">Am J Hum Genet. </span>2015;<span class="ref-vol">97</span>:878–85.</span> [<a href="/pmc/articles/PMC4678414/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4678414</span></a>] [<a href="/pubmed/26626625" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26626625</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.lorenzoni.2013.155">Lorenzoni PJ, Scola RH, Kay CS, Filla L, Miranda AP, Pinheiro JM, Chaouch A, Lochm&#x000fc;ller H, Werneck LC. Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation. <span><span class="ref-journal">J Neurol Sci. </span>2013;<span class="ref-vol">331</span>:155–7.</span> [<a href="/pubmed/23790237" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23790237</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.maselli.2010.2370">Maselli RA, Arredondo J, Cagney O, Ng JJ, Anderson JA, Williams C, Gerke BJ, Soliven B, Wollmann RL. Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:2370–9.</span> [<a href="/pmc/articles/PMC2876883/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2876883</span></a>] [<a href="/pubmed/20371544" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20371544</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.maselli.2012.1123">Maselli RA, Fernandez JM, Arredondo J, Navarro C, Ngo M, Beeson D, Cagney O, Williams DC, Wollmann RL, Yarov-Yarovoy V, Ferns MJ. LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin. <span><span class="ref-journal">Hum Genet. </span>2012;<span class="ref-vol">131</span>:1123–35.</span> [<a href="/pmc/articles/PMC4795461/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4795461</span></a>] [<a href="/pubmed/22205389" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22205389</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.maselli.2009.203">Maselli RA, Ng JJ, Anderson JA, Cagney O, Arredondo J, Williams C, Wessel HB, Abdel-Hamid H, Wollmann RL. Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome. <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:203–8.</span> [<a href="/pmc/articles/PMC2643050/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2643050</span></a>] [<a href="/pubmed/19251977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19251977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.mihaylova.2009.1926">Mihaylova V, Salih MA, Mukhtar MM, Abuzeid HA, El-Sadig SM, von der Hagen M, Huebner A, N&#x000fc;rnberg G, Abicht A, M&#x000fc;ller JS, Lochm&#x000fc;ller H, Guergueltcheva V. Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">73</span>:1926–8.</span> [<a href="/pubmed/19949040" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19949040</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.milone.1999.a188">Milone M, Shen XM, Ohno K, Harper MC, Fukudome T, Stilling G, Brengman JM, Engel AG. Unusual congenital myasthenic syndrome (CMS) with endplate AChR deficiency caused by alpha- subunit mutations and a remitting-relapsing clinical course. <span><span class="ref-journal">Neurology. </span>1999;<span class="ref-vol">52</span>:A188.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.milone.2009.228">Milone M, Shen XM, Selcen D, Ohno K, Brengman J, Iannaccone ST, Harper CM, Engel AG. Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">73</span>:228–35.</span> [<a href="/pmc/articles/PMC2715575/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2715575</span></a>] [<a href="/pubmed/19620612" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19620612</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.monies.2014.353">Monies DM, Al-Hindi HN, Al-Muhaizea MA, Jaroudi DJ, Al-Younes B, Naim EA, Wakil SM, Meyer BF, Bohlega S. Clinical and pathological heterogeneity of a congenital disorder of glycosylation manifesting as a myasthenic/myopathic syndrome. <span><span class="ref-journal">Neuromuscul Disord. </span>2014;<span class="ref-vol">24</span>:353–9.</span> [<a href="/pubmed/24461433" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24461433</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.morar.2004.596">Morar B, Gresham D, Angelicheva D, Tournev I, Gooding R, Guergueltcheva V, Schmidt C, Abicht A, Lochmuller H, Tordai A, Kalmar L, Nagy M, Karcagi V, Jeanpierre M, Herczegfalvi A, Beeson D, Venkataraman V, Warwick Carter K, Reeve J, de Pablo R, Kucinskas V, Kalaydjieva L. Mutation history of the roma/gypsies. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">75</span>:596–609.</span> [<a href="/pmc/articles/PMC1182047/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1182047</span></a>] [<a href="/pubmed/15322984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15322984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.m_ller.2004a.e104">M&#x000fc;ller JS, Abicht A, Burke G, Cossins J, Richard P, Baumeister SK, Stucka R, Eymard B, Hantai D, Beeson D, Lochmuller H. The Congenital Myasthenic Syndrome mutation RAPSN N88K derives from an ancient Indo-European founder. <span><span class="ref-journal">J Med Genet. </span>2004a;<span class="ref-vol">41</span>:e104.</span> [<a href="/pmc/articles/PMC1735862/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735862</span></a>] [<a href="/pubmed/15286164" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15286164</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.m_ller.2004b.744">M&#x000fc;ller JS, Abicht A, Christen HJ, Stucka R, Schara U, Mortier W, Huebner A, Lochmuller H. A newly identified chromosomal microdeletion of the rapsyn gene causes a congenital myasthenic syndrome. <span><span class="ref-journal">Neuromuscul Disord. </span>2004b;<span class="ref-vol">14</span>:744–9.</span> [<a href="/pubmed/15482960" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15482960</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.m_ller.2006.2784">M&#x000fc;ller JS, Baumeister SK, Schara U, Cossins J, Krause S, von der Hagen M, Huebner A, Webster R, Beeson D, Lochm&#x000fc;ller H, Abicht A. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:2784–93.</span> [<a href="/pubmed/16916845" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16916845</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.m_ller.2007a.1497">M&#x000fc;ller JS, Herczegfalvi A, Vilchez JJ, Colomer J, Bachinski LL, Mihaylova V, Santos M, Schara U, Deschauer M, Shevell M, Poulin C, Dias A, Soudo A, Hietala M, A&#x000e4;rimaa T, Krahe R, Karcagi V, Huebner A, Beeson D, Abicht A, Lochm&#x000fc;ller H. Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. <span><span class="ref-journal">Brain. </span>2007a;<span class="ref-vol">130</span>:1497–506.</span> [<a href="/pubmed/17439981" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17439981</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.m_ller.2007b.1">M&#x000fc;ller JS, Mihaylova V, Abicht A, Lochm&#x000fc;ller H. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission. <span><span class="ref-journal">Expert Rev Mol Med. </span>2007b;<span class="ref-vol">9</span>:1–20.</span> [<a href="/pubmed/17686188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17686188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.nichols.1999.439">Nichols P, Croxen R, Vincent A, Rutter R, Hutchinson M, Newsom-Davis J, Beeson D. Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome. <span><span class="ref-journal">Ann Neurol. </span>1999;<span class="ref-vol">45</span>:439–43.</span> [<a href="/pubmed/10211467" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10211467</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.nicole.2014.2429">Nicole S, Chaouch A, Torbergsen T, Bauch&#x000e9; S, de Bruyckere E, Fontenille MJ, Horn MA, van Ghelue M, L&#x000f8;seth S, Issop Y, Cox D, M&#x000fc;ller JS, Evangelista T, St&#x000e5;lberg E, Ioos C, Barois A, Brochier G, Sternberg D, Fournier E, Hanta&#x000ef; D, Abicht A, Dusl M, Laval SH, Griffin H, Eymard B, Lochm&#x000fc;ller H. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy. <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:2429–43.</span> [<a href="/pubmed/24951643" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24951643</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.niimi.2001.566">Niimi M, Ogawara T, Yamashita T, Yamamoto Y, Ueyama A, Kambe T, Okamoto T, Ban T, Tamanoi H, Ozaki K, Fujiwara T, Fukui H, Takahashi EI, Kyushiki H, Tanigami A. Identification of GFAT1-L, a novel splice variant of human glutamine: fructose-6-phosphate amidotransferase (GFAT1) that is expressed abundantly in skeletal muscle. <span><span class="ref-journal">J Hum Genet. </span>2001;<span class="ref-vol">46</span>:566–71.</span> [<a href="/pubmed/11587069" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11587069</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.ohkawara.2014.1856">Ohkawara B, Cabrera-Serrano M, Nakata T, Milone M, Asai N, Ito K, Ito M, Masuda A, Ito Y, Engel AG, Ohno K. LRP4 third &#x003b2;-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner. <span><span class="ref-journal">Hum Mol Genet. </span>2014;<span class="ref-vol">23</span>:1856–68.</span> [<a href="/pmc/articles/PMC3943522/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3943522</span></a>] [<a href="/pubmed/24234652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24234652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.ohno.1999.131">Ohno K, Anlar B, Engel AG. Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetylcholine receptor epsilon subunit gene. <span><span class="ref-journal">Neuromuscul Disord. </span>1999;<span class="ref-vol">9</span>:131–5.</span> [<a href="/pubmed/10382905" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10382905</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.ohno.1998.9654">Ohno K, Brengman J, Tsujino A, Engel AG. Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1998;<span class="ref-vol">95</span>:9654–9.</span> [<a href="/pmc/articles/PMC21394/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC21394</span></a>] [<a href="/pubmed/9689136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9689136</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.ohno.2004a.117">Ohno K, Engel AG. Congenital myasthenic syndromes: gene mutations. <span><span class="ref-journal">Neuromuscul Disord. </span>2004a;<span class="ref-vol">14</span>:117–22.</span> [<a href="/pubmed/14702950" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14702950</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.ohno.2004b.e8">Ohno K, Engel AG. Lack of founder haplotype for the rapsyn mutation; N88K is an ancient founder mutation or arises from multiple founders. <span><span class="ref-journal">J Med Genet. </span>2004b;<span class="ref-vol">41</span>:e8.</span> [<a href="/pmc/articles/PMC1757267/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1757267</span></a>] [<a href="/pubmed/14729848" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14729848</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.ohno.2000.162">Ohno K, Engel AG, Brengman JM, Shen XM, Heidenreich F, Vincent A, Milone M, Tan E, Demirci M, Walsh P, Nakano S, Akiguchi I. The spectrum of mutations causing end-plate acetylcholinesterase deficiency. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">47</span>:162–70.</span> [<a href="/pubmed/10665486" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10665486</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.ohno.2002.875">Ohno K, Engel AG, Shen XM, Selcen D, Brengman J, Harper CM, Tsujino A, Milone M. Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:875–85.</span> [<a href="/pmc/articles/PMC379116/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC379116</span></a>] [<a href="/pubmed/11791205" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11791205</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.ohno.2003.739">Ohno K, Sadeh M, Blatt I, Brengman JM, Engel AG. E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>:739–48.</span> [<a href="/pubmed/12651869" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12651869</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.ohno.2001.2017">Ohno K, Tsujino A, Brengman JM, Harper CM, Bajzer Z, Udd B, Beyring R, Robb S, Kirkham FJ, Engel AG. Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2001;<span class="ref-vol">98</span>:2017–22.</span> [<a href="/pmc/articles/PMC29374/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC29374</span></a>] [<a href="/pubmed/11172068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11172068</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.okada.2006.1802">Okada K, Inoue A, Okada M, Murata Y, Kakuta S, Jigami T, Kubo S, Shiraishi H, Eguchi K, Motomura M, Akiyama T, Iwakura Y, Higuchi O, Yamanashi Y. The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. <span><span class="ref-journal">Science. </span>2006;<span class="ref-vol">312</span>:1802–5.</span> [<a href="/pubmed/16794080" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16794080</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.palace.2007.1507">Palace J, Lashley D, Newsom-Davis J, Cossins J, Maxwell S, Kennett R, Jayawant S, Yamanashi Y, Beeson D. Clinical features of the DOK7 neuromuscular junction synaptopathy. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:1507–15.</span> [<a href="/pubmed/17452375" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17452375</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.quiram.1999.1403">Quiram PA, Ohno K, Milone M, Patterson MC, Pruitt NJ, Brengman JM, Sine SM, Engel AG. Mutation causing congenital myasthenia reveals acetylcholine receptor beta/delta subunit interaction essential for assembly. <span><span class="ref-journal">J Clin Invest. </span>1999;<span class="ref-vol">104</span>:1403–10.</span> [<a href="/pmc/articles/PMC409847/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC409847</span></a>] [<a href="/pubmed/10562302" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10562302</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.ravenscroft.2011.793">Ravenscroft G, Sollis E, Charles AK, North KN, Baynam G, Laing NG. Fetal akinesia: review of the genetics of the neuromuscular causes. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:793–801.</span> [<a href="/pubmed/21984750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21984750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.r_gal.2014.1254">R&#x000e9;gal L, Shen XM, Selcen D, Verhille C, Meulemans S, Creemers JW, Engel AG. PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">82</span>:1254–60.</span> [<a href="/pmc/articles/PMC4001208/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4001208</span></a>] [<a href="/pubmed/24610330" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24610330</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.richard.2003.e81">Richard P, Gaudon K, Andreux F, Yasaki E, Prioleau C, Bauche S, Barois A, Ioos C, Mayer M, Routon MC, Mokhtari M, Leroy JP, Fournier E, Hainque B, Koenig J, Fardeau M, Eymard B, Hantai D. Possible founder effect of rapsyn N88K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:e81.</span> [<a href="/pmc/articles/PMC1735489/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735489</span></a>] [<a href="/pubmed/12807980" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12807980</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.rodr_guez_cruz.2014.2234">Rodr&#x000ed;guez Cruz PM, Palace J, Beeson D. Inherited disorders of the neuromuscular junction: an update. <span><span class="ref-journal">J Neurol. </span>2014;<span class="ref-vol">261</span>:2234–43.</span> [<a href="/pubmed/25305004" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25305004</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.schara.2009.828">Schara U, Barisic N, Deschauer M, Lindberg C, Straub V, Strigl-Pill N, Wendt M, Abicht A, M&#x000fc;ller JS, Lochm&#x000fc;ller H. Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations. <span><span class="ref-journal">Neuromuscul Disord. </span>2009;<span class="ref-vol">19</span>:828–32.</span> [<a href="/pubmed/19837590" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19837590</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.schara.2012.184">Schara U, Della Marina A, Abicht A. Congenital myasthenic syndromes: current diagnostic and therapeutic approaches. <span><span class="ref-journal">Neuropediatrics. </span>2012;<span class="ref-vol">43</span>:184–93.</span> [<a href="/pubmed/22911480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22911480</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.selcen.2014.1822">Selcen D, Shen XM, Brengman J, Li Y, Stans AA, Wieben E, Engel AG. DPAGT1 myasthenia and myopathy: genetic, phenotypic, and expression studies. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">82</span>:1822–30.</span> [<a href="/pmc/articles/PMC4035711/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4035711</span></a>] [<a href="/pubmed/24759841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24759841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.selcen.2011.327">Selcen D, Juel VC, Hobson-Webb LD, Smith EC, Stickler DE, Bite AV, Ohno K, Engel AG. Myasthenic syndrome caused by plectinopathy. <span><span class="ref-journal">Neurology. </span>2011;<span class="ref-vol">76</span>:327–36.</span> [<a href="/pmc/articles/PMC3034415/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3034415</span></a>] [<a href="/pubmed/21263134" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21263134</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.selcen.2015.889">Selcen D, Ohkawara B, Shen XM, McEvoy K, Ohno K, Engel AG. Impaired synaptic development, maintenance, and neuromuscular transmission in LRP4-related myasthenia. <span><span class="ref-journal">JAMA Neurol. </span>2015;<span class="ref-vol">72</span>:889–96.</span> [<a href="/pmc/articles/PMC4532561/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4532561</span></a>] [<a href="/pubmed/26052878" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26052878</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.senderek.2011.162">Senderek J, M&#x000fc;ller JS, Dusl M, Strom TM, Guergueltcheva V, Diepolder I, Laval SH, Maxwell S, Cossins J, Krause S, Muelas N, Vilchez JJ, Colomer J, Mallebrera CJ, Nascimento A, Nafissi S, Kariminejad A, Nilipour Y, Bozorgmehr B, Najmabadi H, Rodolico C, Sieb JP, Steinlein OK, Schlotter B, Schoser B, Kirschner J, Herrmann R, Voit T, Oldfors A, Lindbergh C, Urtizberea A, von der Hagen M, H&#x000fc;bner A, Palace J, Bushby K, Straub V, Beeson D, Abicht A, Lochm&#x000fc;ller H. Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">88</span>:162–72.</span> [<a href="/pmc/articles/PMC3035713/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3035713</span></a>] [<a href="/pubmed/21310273" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21310273</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.servais.2013.815">Servais L, Baudoin H, Zehrouni K, Richard P, Sternberg D, Fournier E, Eymard B, Stojkovic T. Pregnancy in congenital myasthenic syndrome. <span><span class="ref-journal">J Neurol. </span>2013;<span class="ref-vol">260</span>:815–9.</span> [<a href="/pubmed/23108489" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23108489</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.shen.2014.2247">Shen XM, Selcen D, Brengman J, Engel AG. Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">83</span>:2247–55.</span> [<a href="/pmc/articles/PMC4277673/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4277673</span></a>] [<a href="/pubmed/25381298" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25381298</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.tansindhunata.2015.1151">Tan-Sindhunata MB, Mathijssen IB, Smit M, Baas F, de Vries JI, van der Voorn JP, Kluijt I, Hagen MA, Blom EW, Sistermans E, Meijers-Heijboer H, Waisfisz Q, Weiss MM, Groffen AJ. Identification of a Dutch founder mutation in MUSK causing fetal akinesia deformation sequence. <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>:1151–7.</span> [<a href="/pmc/articles/PMC4538208/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4538208</span></a>] [<a href="/pubmed/25537362" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25537362</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.tsujino.2003.7377">Tsujino A, Maertens C, Ohno K, Shen XM, Fukuda T, Harper CM, Cannon SC, Engel AG. Myasthenic syndrome caused by mutation of the SCN4A sodium channel. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:7377–82.</span> [<a href="/pmc/articles/PMC165883/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC165883</span></a>] [<a href="/pubmed/12766226" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12766226</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.vogt.2008.222">Vogt J, Harrison BJ, Spearman H, Cossins J, Vermeer S, ten Cate LN, Morgan NV, Beeson D, Maher ER. Mutation analysis of CHRNA1, CHRNB1, CHRND, and RAPSN genes in multiple pterygium syndrome/fetal akinesia patients. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">82</span>:222–7.</span> [<a href="/pmc/articles/PMC2253973/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2253973</span></a>] [<a href="/pubmed/18179903" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18179903</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.vrinten.2014.cd010028">Vrinten C, van der Zwaag AM, Weinreich SS, Scholten RJ, Verschuuren JJ. Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2014;(12):CD010028.</span> [<a href="/pubmed/25515947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25515947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.whittaker.2015.1964">Whittaker RG, Herrmann DN, Bansagi B, Hasan BA, Lofra RM, Logigian EL, Sowden JE, Almodovar JL, Littleton JT, Zuchner S, Horvath R, Lochm&#x000fc;ller H. Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">85</span>:1964–71.</span> [<a href="/pmc/articles/PMC4664120/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4664120</span></a>] [<a href="/pubmed/26519543" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26519543</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cms.REF.witting.2014.350">Witting N, Vissing J. Pharmacologic treatment of downstream of tyrosine kinase 7 congenital myasthenic syndrome. <span><span class="ref-journal">JAMA Neurol. </span>2014;<span class="ref-vol">71</span>:350–4.</span> [<a href="/pubmed/24425145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24425145</span></a>]</div></li></ul></div></div><div id="cms.Chapter_Notes"><h2 id="_cms_Chapter_Notes_">Chapter Notes</h2><div id="cms.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>14 July 2016 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>28 June 2012 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/targeted-mutation-analysis/">targeted mutation analysis</a> of <i>CHRNA1</i> no longer listed in the GeneTests&#x02122; Laboratory Directory as being available clinically</div></li><li class="half_rhythm"><div>22 March 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 September 2006 (aa) Revision: clinical testing available for: mutation scanning of <i>RAPSN</i>, <i>CHAT</i>, <i>COLQ</i>, <i>CHRNB1</i>, and <i>CHRND</i>; <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>CHRNE</i> and <i>CHRNA1</i>; <a class="def" href="/books/n/gene/glossary/def-item/targeted-mutation-analysis/">targeted mutation analysis</a> of <i>RAPSN</i> mutation p.N88K, <i>CHAT</i> mutation p.I305T, and <i>CHRNA1</i> mutation p.G153S; <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for <i>CHAT</i>, <i>CHRNA1</i>, <i>CHRNB1</i>, <i>CHRND</i>, <i>CHRNE</i>, <i>COLQ</i>, and <i>RAPSN</i></div></li><li class="half_rhythm"><div>20 September 2005 (aa) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> for <i>RAPSN</i> clinically available</div></li><li class="half_rhythm"><div>8 August 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 May 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>30 January 2003 (aa) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1168</span><span class="label">PMID: <a href="/pubmed/20301347" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301347</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cmd-overview/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/csc-dys/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1168&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1168/?report=reader">PubReader</a></li><li><a href="/books/NBK1168/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1168" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1168" style="display:none" title="Cite this Page"><div class="bk_tt">Abicht A, Müller J S, Lochmüller H. Congenital Myasthenic Syndromes. 2003 May 9 [Updated 2016 Jul 14]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1168/pdf/Bookshelf_NBK1168.pdf">PDF version of this page</a> (640K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cms.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cms.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cms.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cms.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cms.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cms.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cms.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cms.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cms.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cms.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cms.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2673[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GFPT1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=375790[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">AGRN</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1144[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHRND</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4038[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LRP4</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1798[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DPAGT1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=60482[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC5A7</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6616[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SNAP25</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1140[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHRNB1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1134[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHRNA1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=285489[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DOK7</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1305[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COL13A1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4593[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MUSK</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=199857[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALG14</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1103[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHAT</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=127833[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SYT2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=85365[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALG2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1145[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CHRNE</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6329[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SCN4A</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4649[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MYO9A</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5913[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RAPSN</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8292[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COLQ</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6576[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC25A1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1470846" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1470846" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1470846" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1470846" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/15034473" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].</a><span class="source">[Rev Neurol (Paris). 2004]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Andreux F, Hantaï D, Eymard B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Rev Neurol (Paris). 2004 Feb; 160(2):163-76. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23452772" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].</a><span class="source">[Rev Neurol (Paris). 2013]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Eymard B, Stojkovic T, Sternberg D, Richard P, Nicole S, Fournier E, Béhin A, Laforêt P, Servais L, Romero N, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Rev Neurol (Paris). 2013 Feb; 169 Suppl 1:S45-55. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/18707767" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Congenital myasthenic syndromes in childhood: diagnostic and management challenges.</a><span class="source">[J Neuroimmunol. 2008]</span><div class="brieflinkpop offscreen_noflow">Congenital myasthenic syndromes in childhood: diagnostic and management challenges.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kinali M, Beeson D, Pitt MC, Jungbluth H, Simonds AK, Aloysius A, Cockerill H, Davis T, Palace J, Manzur AY, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Neuroimmunol. 2008 Sep 15; 201-202:6-12. Epub 2008 Aug 15.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301565" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Central Core Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Central Core Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Malicdan MCV, Nishino I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301529" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Myotonia Congenita</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Myotonia Congenita<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dunø M, Colding-Jørgensen E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301347" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301347" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040c58dd21425a2548e60d">Congenital Myasthenic Syndromes - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Congenital Myasthenic Syndromes - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:26:48-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A5D65E040AD110000000000A30039&amp;ncbi_session=CE8A5D65E040C571_0163SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1168%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1168&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1168/&amp;ncbi_pagename=Congenital Myasthenic Syndromes - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A5D65E040C571_0163SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>